Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R70 Cause of death: ICD-10 — R70 2 out of 7 registries used, show all original rules.	3737
4. Check minimum number of events None	3737
5. Include endpoints None	3737
6. Filter based on genotype QC (FinnGen only)	3272

Control definitions (FinnGen only)

Control exclude: R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R7
Name in latin: Ratio sedimenti erythrocytorum elevata et abnormitas viscositatis plasmatis

NAME	R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO
CONTROL_EXCLUDE	R18_ABNORMAL_FINDI_EXAMI_BLOOD_WO_DIAGNOSIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R70
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R70
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3272	1843	1429
Unadjusted period prevalence (%)	0.65	0.65	0.66
Median age at first event (years)	67.19	64.68	70.43

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3382: Matched controls
33820

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D64.9

ICD-10 Finland

Anaemia, unspecified

4.6

323.0

983

2764

M35.3

ICD-10 Finland

Polymyalgia rheumatica

7.1

315.6

526

861

PAW37

NOMESCO Finland

Biopsy of temporal artery

28.3

307.7

225

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

32078.9

307.7

3337

XW000

NOMESCO Finland

Bone marrow biopsy

6.4

227.2

403

696

H02AB06

ATC

prednisolone; systemic

3.2

222.1

2199

12484

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

14.3

212.0

196

145

R50.9

ICD-10 Finland

Fever, unspecified

3.5

204.8

898

3159

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

23.5

175.7

127

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.4

173.5

783

2776

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.5

162.5

658

2172

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

10.2

149.1

171

176

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

140.8

721

2726

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

139.1

2098

13404

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

138.3

1667

9625

L04AX03

ATC

methotrexate; systemic

3.5

133.9

531

1716

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

129.6

1379

7475

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.8

111.0

368

1051

C03CA01

ATC

furosemide; systemic

2.2

110.5

1636

10014

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.3

108.8

466

1570

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

107.8

509

1817

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

105.1

1311

7451

UJF32

NOMESCO Finland

Coloscopy

2.2

98.5

1179

6551

M13.9

ICD-10 Finland

Arthritis, unspecified

3.4

97.9

390

1253

M04AA01

ATC

allopurinol; systemic

2.5

96.0

734

3353

JN4AD

NOMESCO Finland

Body CT examination

2.7

92.2

599

2525

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.5

85.4

311

941

L04AX01

ATC

azathioprine; systemic

4.2

82.0

226

562

J01MA12

ATC

levofloxacin; systemic

2.2

79.0

845

4423

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

72.3

829

4440

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

18.4

69.9

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.8

67.8

156

336

JN4BD

NOMESCO Finland

Extensive body CT

2.5

67.5

495

2189

A02BC02

ATC

pantoprazole; systemic

2.0

66.9

2464

19418

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.0

64.5

317

1144

M31.6

ICD-10 Finland

Other giant cell arteritis

17.0

62.6

A10AC01

ATC

insulin (human); parenteral

2.7

62.4

380

1534

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.0

62.2

109

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

6.4

61.7

104

168

C90.0

ICD-10 Finland

Multiple myeloma

6.2

61.2

106

176

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

60.3

870

5024

L88

ICPC

Rheumatoid/seropositive arthritis

3.5

59.6

216

649

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.8

58.9

330

1276

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

57.6

214

653

A10AB05

ATC

insulin aspart; parenteral

2.6

56.3

352

1437

P01BA02

ATC

hydroxychloroquine; oral

2.6

56.3

364

1511

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

55.9

498

2387

R70.1

ICD-10 Finland

Abnormal plasma viscosity

+∞

55.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

53.9

898

5412

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

53.6

725

4072

A46

ICD-10 Finland

Erysipelas

2.0

52.4

643

3486

I77.6

ICD-10 Finland

Arteritis, unspecified

15.7

52.0

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

51.9

960

5970

H02AB07

ATC

prednisone; oral

2.1

51.6

584

3070

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

50.6

326

1348

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

50.2

853

5155

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.6

49.6

118

261

R06.0

ICD-10 Finland

Dyspnoea

1.8

49.3

1089

7124

M05BA04

ATC

alendronic acid; oral

2.2

48.5

464

2283

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

48.3

158

443

I50.0

ICD-10 Finland

Congestive heart failure

2.3

48.1

427

2037

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

47.8

622

3432

N02AX02

ATC

tramadol; systemic, rectal

1.7

47.7

1530

11071

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

46.6

382

1761

R53

ICD-10 Finland

Malaise and fatigue

1.8

46.5

970

6219

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

6.5

46.0

117

N19

ICD-10 Finland

Unspecified kidney failure

2.9

46.0

223

796

ZX120

NOMESCO Finland

Intravenous

2.3

45.8

397

1873

B03XA02

ATC

darbepoetin alfa; parenteral

4.0

45.6

133

344

A07EC01

ATC

sulfasalazine; oral, rectal

2.4

45.5

324

1403

C03DA01

ATC

spironolactone; oral

2.0

44.9

569

3104

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

44.4

421

2059

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

44.4

366

1690

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

44.4

292

1218

WW500

NOMESCO Finland

Blood transfusion

3.0

44.2

200

686

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

44.1

452

2280

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

43.9

501

2630

A10AE04

ATC

insulin glargine; parenteral

2.2

43.0

396

1913

TGC00

NOMESCO Finland

Bronchial lavation

3.8

42.7

134

365

J01FF01

ATC

clindamycin; systemic

1.8

42.6

939

6090

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

42.3

429

2153

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

10.1

41.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

41.5

479

2522

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

40.8

230

889

J01MA02

ATC

ciprofloxacin; systemic

1.6

40.4

1392

10128

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

40.4

978

6494

N18.8

ICD-10 Finland

Other chronic renal failure

3.5

40.2

141

414

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

40.1

206

758

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

39.9

1031

6963

SPAT1262

SPAT

Handing over of treatment supplies

1.8

39.4

670

4011

R70

ICD-10 Finland

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

392.0

39.1

L04AA06

ATC

mycophenolic acid; systemic

4.8

39.1

186

S97

ICPC

Chronic ulcer skin

2.3

38.8

309

1403

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

7.7

38.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

38.4

655

3922

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

38.3

280

1225

C07AB07

ATC

bisoprolol; oral

1.6

38.2

1867

14707

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

38.2

270

1163

SPAT1263

SPAT

Sampling

1.6

38.2

1417

10456

M10.9

ICD-10 Finland

Gout, unspecified

2.3

37.9

319

1482

J01MA14

ATC

moxifloxacin; systemic

2.1

37.1

363

1792

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

5.6

36.6

128

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.6

36.5

216

854

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.8

36.5

111

296

J01DB01

ATC

cefalexin; oral

1.7

36.0

2670

23135

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

35.9

1293

9432

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.4

35.8

208

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

35.0

500

2824

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

34.5

311

1486

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

34.4

397

2083

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.7

34.1

115

E66.8

ICD-10 Finland

Other obesity

2.7

33.6

182

688

UJF92

NOMESCO Finland

Capsular endoscopy

3.8

33.3

101

269

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.6

33.2

111

316

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

33.1

549

3245

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.5

32.8

114

333

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

32.2

858

5784

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

31.5

241

1073

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

31.4

1037

7358

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.8

31.3

253

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

31.1

327

1655

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.0

31.1

139

473

AA1AD

NOMESCO Finland

CT of head and brain

1.6

30.7

1120

8122

153

Kela drug reimbursment

Lenalidomid

6.4

30.3

L04AA13

ATC

[U] leflunomide

3.4

30.1

108

322

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.6

29.9

173

676

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

29.2

199

842

L28

ICPC

Limited function/disability (L)

1.6

29.1

801

5421

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

28.6

247

1157

N17.8

ICD-10 Finland

Other acute renal failure

4.5

28.5

159

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

28.5

168

663

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

28.5

453

2637

L04AX04

ATC

lenalidomide; oral

6.1

28.4

D64.8

ICD-10 Finland

Other specified anaemias

3.4

28.4

104

314

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

28.4

210

921

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

28.3

716

4743

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

28.0

177

723

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

27.9

375

2068

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.8

27.8

232

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

27.7

224

1022

SPAT1255

SPAT

Intravenous administration of medicine

2.1

27.6

272

1343

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

27.4

157

611

T90

ICPC

Diabetes non-insulin dependent

1.6

27.2

865

6048

A02BC01

ATC

omeprazole; systemic

1.6

27.0

965

6922

ZXD05

NOMESCO Finland

Urgent procedure

1.5

26.7

980

7070

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

26.6

213

967

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

26.5

1142

8526

A11CC03

ATC

alfacalcidol; systemic

3.1

26.4

110

360

TK800

NOMESCO Finland

Hemodialysis

3.5

26.3

270

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.4

26.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

26.2

1555

12371

A05AA02

ATC

ursodeoxycholic acid; oral

4.4

26.2

153

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

26.1

651

4286

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

25.9

619

4029

R80

ICD-10 Finland

Isolated proteinuria

5.8

25.8

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

25.7

682

4556

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.0

25.7

293

1525

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.2

25.6

105

340

A10AE05

ATC

insulin detemir; parenteral

2.3

25.5

201

906

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.9

25.4

125

449

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

25.3

1129

8467

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

25.2

430

2550

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

25.2

158

643

N02BE01

ATC

paracetamol; systemic, rectal

1.7

25.2

2933

26747

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

25.2

346

1920

H02AB09

ATC

hydrocortisone; systemic

3.2

24.9

310

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

24.9

120

427

AA1AA

NOMESCO Finland

Head X-ray examination

4.9

24.8

111

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.9

24.8

117

411

M31.3

ICD-10 Finland

Wegener granulomatosis

9.2

24.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

24.6

566

3644

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.4

24.6

272

E0000UV, ,

ATC

1.5

24.6

1329

10343

ZX108

NOMESCO Finland

Inhalation

6.2

24.5

SPAT1254

SPAT

Administration of medicine

1.7

24.3

563

3630

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

24.3

161

672

SPAT1301

SPAT

No procedures

1.5

24.3

1062

7919

B01AB05

ATC

enoxaparin; parenteral

1.5

24.3

1076

8045

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.0

24.2

176

A10BA02

ATC

metformin; oral

1.5

24.1

1009

7452

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

24.0

136

526

C08CA01

ATC

amlodipine; oral

1.5

23.9

1408

11124

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.1

23.7

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

5.1

23.7

100

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

23.7

311

1699

R03AC02

ATC

salbutamol; inhalant

1.4

23.7

1678

13713

A03

ICPC

Fever

1.7

23.6

468

2894

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

23.6

225

1096

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

23.5

2195

18872

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

23.4

169

734

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

23.4

1281

9969

R03BB04

ATC

tiotropium bromide; inhalant

1.8

23.1

406

2426

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

23.0

914

6668

G47.3

ICD-10 Finland

Sleep apnoea

1.6

22.8

666

4539

I50.1

ICD-10 Finland

Left ventricular failure

2.1

22.7

227

1125

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

22.7

114

415

A06AD11

ATC

lactulose; oral

1.6

22.4

612

4106

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

22.0

261

1376

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

21.7

637

4340

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

21.5

346

2012

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.6

21.5

113

ZXE00

NOMESCO Finland

One hour or less

1.4

21.5

1199

9323

XG410

NOMESCO Finland

Flow-volume spirometry

2.4

21.5

155

673

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

21.0

1342

10681

WW300

NOMESCO Finland

Transfer of autologic stem cells

8.5

21.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

20.9

920

6830

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

20.8

194

936

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.8

20.8

168

NHQ40

NOMESCO Finland

Amputation of toe

3.3

20.8

240

R60.0

ICD-10 Finland

Localized oedema

1.6

20.7

476

3056

329

Kela drug reimbursment

Lenalidomide

6.2

20.6

A28

ICPC

Limited function/disability NOS

1.5

20.5

762

5460

B01AA03

ATC

warfarin; systemic

1.5

20.4

786

5673

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

20.4

201

992

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.1

20.3

135

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.7

20.3

112

428

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.7

20.3

102

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.4

20.3

144

621

H02AB04

ATC

methylprednisolone; systemic

1.6

20.2

473

3047

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

6.2

20.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

20.2

926

6922

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

20.1

114

442

A02BC05

ATC

esomeprazole; systemic

1.4

20.0

1264

10016

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

19.9

395

2437

N02AA05

ATC

oxycodone; systemic

1.5

19.9

717

5102

R02

ICPC

Shortness of breath/dyspnoea

1.6

19.7

483

3147

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

19.7

196

971

N03AX16

ATC

[U] pregabalin

1.5

19.6

741

5322

A10BB12

ATC

glimepiride; oral

1.8

19.6

289

1636

N18.0

ICD-10 Finland

End-stage renal disease

4.0

19.6

139

9761/3-C42.0

ICD-O-3

Waldenstrom macroglobulinemia of blood

17.8

19.5

R77.1

ICD-10 Finland

Abnormality of globulin

40.3

19.5

A10BH05

ATC

linagliptin; oral

2.0

19.4

214

1100

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.9

19.3

309

E66.9

ICD-10 Finland

Obesity, unspecified

2.5

19.1

117

471

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.2

19.0

243

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

18.9

1194

9434

D07AC01

ATC

betamethasone; topical

1.4

18.8

1136

8906

R76.0

ICD-10 Finland

Raised antibody titre

+∞

18.8

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.7

18.7

101

382

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

18.7

1328

10706

E000001, ,

ATC

1.5

18.5

600

4166

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.9

18.5

317

A02BC03

ATC

lansoprazole; oral

1.4

18.4

943

7176

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

18.3

112

451

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

7.5

18.2

OAB50, ,

SPAT

1.8

18.0

271

1544

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

17.9

180

894

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.9

17.9

P01AB01

ATC

metronidazole; oral, rectal

1.4

17.8

1182

9398

J01CA04

ATC

amoxicillin; systemic

1.4

17.7

2479

22260

B82

ICPC

Anaemia other/unspecified

2.4

17.7

127

550

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

17.7

345

2117

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

17.6

272

1561

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.7

17.5

355

M10.0

ICD-10 Finland

Idiopathic gout

2.2

17.5

142

649

R81

ICPC

Pneumonia

2.2

17.5

144

662

T82

ICPC

Obesity

2.4

17.4

116

486

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.8

17.4

142

N03AX12

ATC

[U] gabapentin; oral

1.6

17.4

511

3468

JN6JR

NOMESCO Finland

Extensive PET-CT of whole body metabolism (crown to foot)

28.9

17.4

A10BH01

ATC

sitagliptin; oral

1.7

17.4

339

2080

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

17.4

167

816

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

17.3

345

M45

ICD-10 Finland

Ankylosing spondylitis

3.2

17.1

222

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

17.1

2076

18145

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.8

17.1

303

R05

ICD-10 Finland

Cough

1.5

17.0

661

4758

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

17.0

168

A10AB01

ATC

insulin (human); parenteral

2.5

17.0

108

443

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.1

16.9

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

16.9

870

6605

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.0

16.9

118

N05CF01

ATC

zopiclone; oral

1.4

16.9

1092

8626

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

16.9

119

512

N06AX21

ATC

duloxetine; oral

1.7

16.7

355

2227

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

16.6

584

4116

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.5

16.6

WX892

NOMESCO Finland

Monitored bed care

1.8

16.5

259

1493

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

23.1

16.4

TPX00

NOMESCO Finland

Biopsy of artery or vein

23.1

16.4

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

16.4

194

1022

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.7

16.4

139

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

16.3

513

3530

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

16.3

239

M10.3

ICD-10 Finland

Gout due to impairment of renal function

5.7

16.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

16.3

620

4440

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

16.3

300

1811

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

16.3

278

1643

WZC30

NOMESCO Finland

Teaching

1.5

16.2

516

3561

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

6.5

16.2

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

16.2

792

5952

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.9

16.1

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

16.1

323

1996

WX872

NOMESCO Finland

Intensive care

2.0

16.1

172

875

ZY010

NOMESCO Finland

Hospital outpatient

2.2

16.0

136

633

A07AA02

ATC

nystatin; oral

1.9

16.0

218

1204

J01FA06

ATC

roxithromycin; oral

1.4

16.0

1211

9795

C10AA01

ATC

simvastatin; oral

1.4

15.9

1508

12622

Z3231

NOMESCO Finland

Registered nurse

1.4

15.8

836

6365

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

15.8

196

1049

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

14.5

15.8

C02AC05

ATC

moxonidine; oral

2.0

15.8

175

901

J94.9

ICD-10 Finland

Pleural condition, unspecified

5.2

15.8

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.0

15.7

N06AX16

ATC

venlafaxine; oral

1.6

15.7

369

2374

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

6.9

15.7

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.3

15.6

J01AA02

ATC

doxycycline; systemic

1.4

15.6

2450

22130

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

15.5

371

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

15.5

423

2821

R51.80

ICD-10 Finland

Headache

1.6

15.4

435

2921

A12AA04

ATC

calcium carbonate; oral

3.1

15.4

205

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

15.4

559

3964

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

15.3

164

834

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.6

15.3

136

M79.6

ICD-10 Finland

Pain in limb

1.4

15.3

1319

10860

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

14.8

15.3

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

15.3

177

925

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

15.2

780

5900

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

15.2

408

2708

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.4

15.2

156

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

15.2

113

498

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

15.2

333

2105

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.9

15.2

244

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.5

15.2

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.8

15.2

266

M54.5

ICD-10 Finland

Low back pain

1.4

15.1

1055

8404

C09AA02

ATC

enalapril; systemic

1.4

15.1

698

5182

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

15.1

467

3200

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

15.1

114

506

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

6.3

15.0

J01XX08

ATC

linezolid; systemic

4.8

14.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

14.9

1282

10541

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.0

14.9

214

SPAT1229

SPAT

Assessment of need for aid

1.7

14.9

294

1808

ED1AA

NOMESCO Finland

Mandibular X-ray examination

5.2

14.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.5

14.8

149

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

14.8

750

5660

205

Kela drug reimbursment

Chronic hypertension

1.4

14.7

1015

8061

R04.0

ICD-10 Finland

Epistaxis

1.7

14.7

278

1689

I50

ICD-10 Finland

Heart failure

2.1

14.7

136

655

A01

ICPC

Pain general/multiple sites

1.6

14.7

343

2201

A10AD05

ATC

insulin aspart; parenteral

2.6

14.7

328

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

14.6

364

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

14.6

201

1114

C10AA05

ATC

atorvastatin; oral

1.3

14.6

1414

11827

A10AB04

ATC

insulin lispro; parenteral

2.5

14.5

371

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

14.5

550

3928

L01AA03

ATC

melphalan; systemic

6.6

14.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

14.4

622

4557

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

14.3

559

4015

WW200

NOMESCO Finland

Immunization

2.6

14.3

338

M46.4

ICD-10 Finland

Discitis, unspecified

5.5

14.3

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.3

14.3

103

448

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.9

14.3

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.3

14.1

103

451

E06.1

ICD-10 Finland

Subacute thyroiditis

4.8

14.0

J01DA01

ATC

[U] cefalexin

1.3

14.0

1883

16465

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.0

14.0

201

R31

ICD-10 Finland

Unspecified haematuria

1.6

14.0

355

2326

3AC01, ,

NOMESCO Finland

3.8

13.9

112

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

13.9

532

3804

127

Kela drug reimbursment

Transplant complication

3.5

13.9

131

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

13.9

237

1401

C01DA14

ATC

isosorbide mononitrate; oral

1.4

13.8

650

4834

B03XA01

ATC

erythropoietin; parenteral

3.7

13.7

118

L04AD01

ATC

ciclosporin; systemic

3.1

13.7

177

N06AA09

ATC

amitriptyline; systemic

1.6

13.7

316

2022

M25.5

ICD-10 Finland

Pain in joint

1.4

13.7

914

7208

M05BX04

ATC

denosumab; parenteral

1.7

13.7

249

1498

M35.1

ICD-10 Finland

Other overlap syndromes

5.1

13.6

C09AA05

ATC

ramipril; oral

1.4

13.6

874

6849

L01BA01

ATC

methotrexate; systemic

2.1

13.6

124

595

K76.9

ICD-10 Finland

Liver disease, unspecified

3.4

13.5

143

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

13.5

122

583

J86.9

ICD-10 Finland

Pyothorax without fistula

3.7

13.4

115

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

13.4

129

631

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

13.4

124

598

B01AB10

ATC

tinzaparin; parenteral

1.6

13.4

341

2234

M79.7

ICD-10 Finland

Fibromyalgia

2.3

13.4

100

442

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

13.4

392

SPAT1211

SPAT

Application of soft bandage

1.6

13.3

285

1789

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

13.3

260

1594

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.1

13.3

175

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.6

13.3

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

13.3

119

567

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

13.3

223

1312

A04

ICPC

Weakness/tiredness general

1.5

13.3

532

3838

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.6

13.2

121

SPAT1240

SPAT

Therapeutic discussion

1.7

13.2

243

1466

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

13.2

212

1231

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

13.2

352

D07AC13

ATC

mometasone; topical

1.4

13.1

848

6644

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.7

13.1

247

T89

ICPC

Diabetes insulin dependent

2.2

13.1

107

491

A10BJ02

ATC

liraglutide; parenteral

2.5

13.1

347

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

13.1

402

2747

L01AA01

ATC

cyclophosphamide; systemic

4.8

13.1

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

13.0

306

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

13.0

380

2570

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

12.9

312

2018

J94.8

ICD-10 Finland

Other specified pleural conditions

2.6

12.9

272

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

12.9

364

2441

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.8

12.9

100

SPAT1310

SPAT

Counselling related to known health issue

1.3

12.9

944

7540

WVA20

NOMESCO Finland

Medicine administration

2.3

12.8

406

A07AA09

ATC

vancomycin; oral

2.9

12.8

206

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

12.8

921

7335

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

12.8

345

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.7

12.8

228

1365

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.1

12.8

164

M05BA07

ATC

risedronic acid; oral

2.0

12.7

130

651

R4190

NOMESCO Finland

Nutritional therapy

2.2

12.7

106

491

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

12.6

175

972

H3603, E103,

ICD-10 Finland

4.9

12.6

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

12.6

135

688

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

12.6

230

1385

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

12.6

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.9

12.5

L17

ICPC

Foot/toe symptom/complaint

1.3

12.5

926

7402

Z2446

NOMESCO Finland

Social worker

1.8

12.5

188

1071

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

12.4

339

2256

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

5.6

12.4

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.0

12.4

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

4.9

12.4

K92.1

ICD-10 Finland

Melaena

1.8

12.4

198

1149

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4.0

12.4

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.9

12.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

12.3

860

6809

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

12.3

192

1107

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.0

12.3

133

681

ZXA10

NOMESCO Finland

Bilateral

1.4

12.2

593

4423

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

12.2

384

2635

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

12.2

907

7248

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

12.2

239

1467

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

12.2

202

1185

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

3.7

12.1

100

UJD02

NOMESCO Finland

Gastroscopy

1.8

12.1

166

920

WX002

NOMESCO Finland

Sedation and analgesia

1.4

12.1

601

4504

P03

ICPC

Feeling depressed

1.7

12.0

220

1325

ZX112

NOMESCO Finland

Subcutaneous

2.5

12.0

294

UKC02

NOMESCO Finland

Cystoscopy

1.4

12.0

539

3964

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

12.0

155

842

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

12.0

107

510

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

12.0

307

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.5

11.9

115

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

11.9

179

1020

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

46.8

11.9

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

11.8

149

803

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.1

11.8

156

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.5

11.8

116

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

11.8

180

1030

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

11.8

315

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

11.8

104

493

JN4CD

NOMESCO Finland

Very extensive body CT

2.0

11.8

125

635

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.2

11.8

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.4

11.8

121

M10

ICD-10 Finland

Gout

1.9

11.8

153

833

A10BJ06

ATC

semaglutide; parenteral

1.9

11.7

140

741

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.9

11.7

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

11.7

500

3646

D72.1

ICD-10 Finland

Eosinophilia

5.5

11.6

V03AE01

ATC

polystyrene sulfonate; oral

2.9

11.6

195

TNG10

NOMESCO Finland

Puncture of knee

3.2

11.6

137

N06AX11

ATC

mirtazapine; oral

1.3

11.6

1018

8322

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

11.6

214

1293

E86

ICD-10 Finland

Volume depletion

2.1

11.6

103

490

R06AE07

ATC

cetirizine; oral

1.3

11.6

1211

10140

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

11.6

393

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.5

11.5

294

E66

ICD-10 Finland

Obesity

2.0

11.5

126

647

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

11.5

459

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

11.4

235

1460

OAB72

NOMESCO Finland

Weight control and weight loss guidance

4.4

11.4

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.7

11.4

C09CA01

ATC

losartan; oral

1.3

11.3

839

6691

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

11.3

148

808

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

11.3

101

482

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.9

11.3

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.9

11.3

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

11.3

143

773

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

11.3

132

695

WX402

NOMESCO Finland

General anaesthesia

1.4

11.2

584

4405

SPAT1260

SPAT

Consultation of another employee

1.4

11.2

527

3906

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

11.2

418

D07AB08

ATC

desonide; topical

1.5

11.2

310

2070

L04AA01

ATC

[U] ciclosporin

3.1

11.2

151

N05AH04

ATC

quetiapine; oral

1.4

11.1

464

3364

PAA99

NOMESCO Finland

Exploration of other arterial branch originating from aortic arch arteries

20.1

11.1

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.0

11.1

162

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.9

11.1

R11

ICD-10 Finland

Nausea and vomiting

1.6

11.1

280

1830

A41.8

ICD-10 Finland

Other specified sepsis

2.3

11.1

337

N03AX09

ATC

lamotrigine; oral

2.1

11.0

104

506

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

11.0

212

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

11.0

120

616

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

11.0

231

1444

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

4.4

11.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

10.9

453

3281

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

10.9

284

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

10.9

552

4143

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

10.8

756

5970

M79.1

ICD-10 Finland

Myalgia

1.5

10.8

398

2818

S18

ICPC

Laceration/cut

1.3

10.8

1455

12551

A10AA01, ,

ATC

2.5

10.8

279

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.2

10.8

379

A10AE06

ATC

insulin degludec; parenteral

2.1

10.8

444

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

10.8

1065

8832

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

21.5

10.7

WX722

NOMESCO Finland

PEEP

1.9

10.7

143

787

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

10.7

186

1107

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

10.6

128

680

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

10.6

343

2366

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.5

10.6

252

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

10.6

160

914

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.7

10.5

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.5

10.5

271

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

10.5

397

2826

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

10.5

436

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

10.4

410

2941

R55

ICD-10 Finland

Syncope and collapse

1.5

10.4

380

2687

B80

ICPC

Iron deficiency anaemia

2.2

10.3

399

D07XC01

ATC

betamethasone; topical

1.5

10.3

354

2471

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

5.1

10.3

RJ421, ,

NOMESCO Finland

5.1

10.3

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.5

10.3

102

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

10.2

418

3018

K77

ICPC

Heart failure

2.1

10.2

467

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.8

10.2

187

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

10.1

514

3855

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

10.1

537

4057

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

3.9

10.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

10.1

224

1420

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

10.1

443

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

10.0

181

1088

H3601, E103,

ICD-10 Finland

4.5

10.0

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

10.0

372

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

4.6

10.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

10.0

253

1655

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.2

10.0

119

A12BA01

ATC

potassium chloride; oral

1.7

10.0

181

1089

L04AK01

ATC

leflunomide; oral

4.1

10.0

SPAT1312

SPAT

General health counselling

1.3

9.9

887

7240

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

9.9

140

783

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

3.8

9.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

9.9

459

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

9.9

354

C01AA05

ATC

digoxin; systemic

1.5

9.9

336

2341

C09BA02

ATC

enalapril and diuretics; systemic

1.5

9.9

269

1789

J01CF05

ATC

flucloxacillin; systemic

1.7

9.9

198

1224

A10BK01

ATC

dapagliflozin; oral

1.6

9.9

230

1476

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.4

9.8

261

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

9.8

258

1701

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

9.8

441

A07EA06

ATC

budesonide; oral, local oral

2.0

9.8

101

509

TAB00

NOMESCO Finland

Lumbar puncture

1.9

9.8

118

628

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

9.8

174

1042

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

9.7

877

7165

J05AB01

ATC

aciclovir; systemic

1.3

9.7

628

4894

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

9.7

190

1168

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

9.7

100

505

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

9.6

391

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.3

9.6

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.8

9.6

165

A29

ICPC

General symptom/complaint other

1.4

9.6

431

3167

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.8

9.5

160

AN1

Coronary angiography

1.4

9.5

380

2731

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

9.5

1065

8943

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.0

9.5

5BA08, ,

NOMESCO Finland

4.0

9.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

9.5

1056

8859

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.6

9.5

200

R42

ICD-10 Finland

Dizziness and giddiness

1.3

9.5

758

6090

L04AB04

ATC

adalimumab; parenteral

2.5

9.4

218

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.2

9.4

381

R77.0

ICD-10 Finland

Abnormality of albumin

100.3

9.4

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

9.4

115

615

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

9.4

119

644

A07EC02

ATC

mesalazine; oral, rectal

1.8

9.4

139

790

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

9.4

166

993

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

9.4

273

1843

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.5

9.4

231

M31.7

ICD-10 Finland

Microscopic polyangiitis

12.4

9.3

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

4.0

9.3

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.5

9.3

220

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.3

694

5522

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

9.3

329

2313

S01

ICPC

Pain/tenderness of skin

1.8

9.3

143

823

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.2

9.2

365

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.9

9.2

152

SPAT1216

SPAT

Assessment of functional ability

1.4

9.2

549

4223

J01EA01

ATC

trimethoprim; systemic

1.3

9.2

810

6589

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.5

9.2

239

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

9.2

127

707

E83.50

ICD-10 Finland

Hypercalcemia

2.6

9.2

192

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

9.1

216

1391

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

9.1

118

643

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

9.1

242

1600

S20

ICPC

Corn/callosity

2.2

9.1

360

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

9.1

277

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.1

9.1

387

RJ410, ,

NOMESCO Finland

5.0

9.1

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

9.1

199

1258

WX723

NOMESCO Finland

CPAP therapy

1.9

9.1

109

580

C07AB02

ATC

metoprolol; systemic

1.3

9.1

706

5647

R50.1

ICD-10 Finland

Persistent fever

11.5

9.1

SPAT1325

SPAT

Vaccination

1.3

9.0

1053

8873

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.4

9.0

235

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.4

9.0

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.8

9.0

165

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

10.0

9.0

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.9

9.0

103

539

C08CA13

ATC

lercanidipine; oral

1.4

9.0

482

3645

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.7

9.0

H36.01

ICD-10 Finland

Diabetic maculopathy

2.8

9.0

160

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.1

8.9

363

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

3.6

8.9

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

8.9

1144

9746

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

8.9

173

1062

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.5

8.9

213

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

8.9

112

606

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

8.8

235

1555

318

Kela drug reimbursment

Teriparatide

3.6

8.8

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

8.8

170

1041

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

8.8

1152

9835

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.8

251

1687

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

3.5

8.8

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.2

8.8

108

SPAT1139

SPAT

Nutrition survey

1.9

8.8

115

630

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.3

8.7

R03BA05

ATC

fluticasone; inhalant

1.4

8.7

491

3742

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

8.7

209

B01AC04

ATC

clopidogrel; oral

1.3

8.7

565

4400

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.9

8.7

106

567

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.9

8.7

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

8.7

483

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

3.6

8.7

A01AB09

ATC

miconazole; local oral

1.5

8.7

271

1857

E87.6

ICD-10 Finland

Hypokalaemia

1.8

8.6

116

640

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

8.6

235

1563

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.7

8.6

169

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.2

8.6

104

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

8.6

198

1267

J04AB02

ATC

rifampicin; systemic

2.7

8.6

175

207

Kela drug reimbursment

Chronic arrhythmias

1.3

8.6

581

4551

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

8.6

110

598

I20.09

ICD-10 Finland

Unstable angina

1.6

8.6

201

1292

B01AF02

ATC

apixaban; oral

1.4

8.6

485

3699

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

8.5

236

1576

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

8.5

261

1782

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

8.5

119

666

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

8.5

210

1368

N02BF01

ATC

gabapentin; oral

1.5

8.5

290

2024

L16

ICPC

Ankle symptom/complaint

1.4

8.4

322

2295

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

8.4

269

1851

K86.2

ICD-10 Finland

Cyst of pancreas

2.8

8.4

143

J46

ICD-10 Finland

Status asthmaticus

2.0

8.4

454

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

8.4

510

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.6

8.4

160

Kela drug reimbursment

exenatide

2.3

8.4

256

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.4

595

4694

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.4

745

6061

A10AA02, ,

ATC

1.9

8.3

504

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.0

8.3

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.3

296

2081

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

8.3

161

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.0

8.3

117

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.1

8.3

381

N06AX12

ATC

bupropion; oral

1.8

8.3

127

730

RJ411, ,

NOMESCO Finland

4.1

8.3

K08.3

ICD-10 Finland

Retained dental root

1.5

8.2

228

1522

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

8.2

713

5776

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

8.2

180

1138

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

8.2

212

1394

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

8.2

343

2485

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

8.2

600

4752

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.2

8.2

WX882

NOMESCO Finland

High dependency care

2.0

8.2

424

WVA20, ,

SPAT

1.8

8.2

109

601

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.9

8.2

129

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

8.1

157

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

8.1

176

1110

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.7

8.1

136

802

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

4.5

8.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

8.1

495

WX213

NOMESCO Finland

Lower leg blockade

3.1

8.1

103

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

8.1

185

1183

N30.0

ICD-10 Finland

Acute cystitis

1.3

8.1

527

4105

R4110, ,

SPAT

1.4

8.1

398

2968

D02AE01

ATC

carbamide; topical

1.6

8.0

173

1090

J45.8

ICD-10 Finland

Mixed asthma

1.9

8.0

504

D05AX52

ATC

calcipotriol, combinations; topical

1.7

8.0

136

805

H15.1

ICD-10 Finland

Episcleritis

2.7

8.0

153

L03AA02

ATC

filgrastim; parenteral

1.9

8.0

470

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

8.0

303

2158

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

3.5

8.0

L04AC07

ATC

tocilizumab; parenteral

7.2

7.9

JN6AD

NOMESCO Finland

CT of torso and neck

2.3

7.9

256

P01

ICPC

Feeling anxious/nervous/tense

1.5

7.9

234

1585

C08CA05

ATC

nifedipine; systemic

1.6

7.9

202

1325

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

7.9

288

2034

NGU00

NOMESCO Finland

Removal of partial prosthesis from knee joint, other or unspecified

7.8

7.9

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.6

7.8

166

N05AA02

ATC

levomepromazine; systemic

1.8

7.8

105

580

V03AE03

ATC

lanthanum carbonate; oral

6.1

7.8

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.5

7.8

178

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.8

398

2983

WX720

NOMESCO Finland

Own respiration

1.7

7.8

133

789

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

7.8

287

2033

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.6

7.8

167

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.7

7.7

A49

ICD-10 Finland

Bacterial infection of unspecified site

4.2

7.7

V03AE02

ATC

sevelamer; oral

4.2

7.7

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

7.7

298

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

7.7

176

1125

ZXA05

NOMESCO Finland

Left side

1.3

7.7

745

6117

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

6.4

7.7

NG1DA

NOMESCO Finland

X-ray of knees

2.2

7.7

279

RJ420, ,

NOMESCO Finland

4.3

7.7

R03AC13

ATC

formoterol; inhalant

1.6

7.7

153

946

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

7.7

204

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.0

7.6

112

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.5

7.6

M05BB03

ATC

alendronic acid and colecalciferol; oral

1.9

7.6

442

M05BA06

ATC

ibandronic acid; systemic

2.0

7.6

380

L04AB01

ATC

etanercept; parenteral

2.6

7.6

157

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

7.6

320

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.6

7.6

169

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

7.6

115

660

XG405

NOMESCO Finland

Education on PEF monitoring

2.5

7.6

187

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

7.6

543

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.2

7.5

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.5

535

4216

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

7.5

174

1116

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

7.5

977

8302

D59.9

ICD-10 Finland

Acquired haemolytic anaemia, unspecified

10.0

7.5

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.8

7.5

H25.8

ICD-10 Finland

Other senile cataract

1.4

7.5

424

3230

W19

ICD-10 Finland

Unspecified fall

1.4

7.5

300

2157

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.9

7.5

119

E000006, ,

ATC

1.6

7.5

191

1254

S76

ICPC

Skin infection other

1.6

7.5

160

1008

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.6

7.4

153

ZXA00

NOMESCO Finland

Right side

1.3

7.4

801

6660

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.6

7.4

165

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.0

7.4

384

H05AA02

ATC

teriparatide; parenteral

3.5

7.4

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.2

7.4

290

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

7.4

148

916

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

6.0

7.4

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.2

7.3

265

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.9

7.3

115

I95.9

ICD-10 Finland

Hypotension, unspecified

2.2

7.3

272

D07AA02

ATC

hydrocortisone; topical

1.4

7.3

351

2605

K55.2

ICD-10 Finland

Angiodysplasia of colon

3.0

7.3

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.2

7.3

253

PE1AT

NOMESCO Finland

Femoral artery PTA

2.4

7.3

197

L03

ICPC

Low back symptom/complaint

1.3

7.2

794

6612

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

3.4

7.2

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

7.2

378

2844

212

Kela drug reimbursment

Gout

2.0

7.2

367

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

6.2

7.2

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

7.2

515

306

Kela drug reimbursment

Erythropoietin and darbepoetin

4.3

7.2

C03AA03

ATC

hydrochlorothiazide; oral

1.4

7.2

303

2198

J01FA09

ATC

clarithromycin; systemic

1.3

7.2

786

6546

N06AB04

ATC

citalopram; systemic

1.3

7.2

577

4624

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

7.1

488

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

7.1

106

605

J01DC02

ATC

cefuroxime; systemic

1.7

7.1

127

763

XX9XE

NOMESCO Finland

Other ultrasound examination

3.1

7.1

Z00.0

ICD-10 Finland

General medical examination

1.3

7.1

551

4391

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

7.1

R50.0

ICD-10 Finland

Fever with chills

7.9

7.1

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

7.1

172

1117

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

7.1

1426

12670

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

7.1

146

912

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.7

7.1

134

819

N06AB03

ATC

fluoxetine; oral

1.4

7.0

311

2277

A04AA01

ATC

ondansetron; systemic, rectal

1.5

7.0

235

1635

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

7.0

128

775

NH2AA

NOMESCO Finland

Heel X-ray examination

3.5

7.0

M01AE02

ATC

naproxen; oral, rectal

1.2

7.0

1541

13808

F34.1

ICD-10 Finland

Dysthymia

1.9

7.0

442

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

7.0

331

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

7.0

100

565

J20

ICD-10 Finland

Acute bronchitis

1.4

7.0

271

1939

NGQ20

NOMESCO Finland

Amputation of lower leg

3.3

7.0

L04AD02

ATC

tacrolimus; systemic

3.3

7.0

SPAT1153

SPAT

Removal of sutures

1.2

6.9

932

7938

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

6.9

149

940

E66.0

ICD-10 Finland

Obesity due to excess calories

2.7

6.9

130

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

13.8

6.9

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.8

6.9

103

590

GX2D5

NOMESCO Finland

Sleep oximetry

3.6

6.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

6.9

546

Z50.0

ICD-10 Finland

Cardiac rehabilitation

2.6

6.8

154

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.5

6.8

172

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

6.8

417

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

6.8

215

1477

Z49.2

ICD-10 Finland

Other dialysis

3.3

6.8

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.9

6.8

403

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.9

6.8

396

M01AH01

ATC

celecoxib; oral

1.3

6.8

516

4099

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

6.8

109

636

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.2

6.8

254

C08CA02

ATC

felodipine; oral

1.4

6.8

320

2367

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

6.8

151

961

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

6.8

P76

ICPC

Depressive disorder

1.6

6.8

136

844

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.5

6.8

155

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

6.8

365

2761

M86.6

ICD-10 Finland

Other chronic osteomyelitis

4.3

6.7

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

6.7

129

791

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

6.7

157

1011

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

3.5

6.7

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

7.2

6.7

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.7

6.7

121

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.4

6.7

H65.2

ICD-10 Finland

Chronic serous otitis media

2.5

6.7

156

SPAT1104

SPAT

Monitoring of emergency patient

1.5

6.7

187

1254

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

6.7

694

5739

A10BJ05

ATC

dulaglutide; parenteral

2.2

6.7

237

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.1

6.6

270

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.8

6.6

116

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

3.7

6.6

M25.9

ICD-10 Finland

Joint disorder, unspecified

2.9

6.6

105

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.0

6.6

324

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

6.6

139

873

TK810

NOMESCO Finland

Hemofiltration

3.6

6.6

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

6.6

203

1389

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

12.3

6.6

N05BA01

ATC

diazepam; systemic, rectal

1.4

6.6

365

2773

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

6.6

210

1448

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

3.3

6.5

NFQ20

NOMESCO Finland

Amputation of femur

2.6

6.5

134

M13.8

ICD-10 Finland

Other specified arthritis

2.8

6.5

117

WW400

NOMESCO Finland

Plasmaferesis

10.0

6.5

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.5

532

4268

N06AB10

ATC

escitalopram; oral

1.3

6.5

464

3655

T78.3

ICD-10 Finland

Angioneurotic oedema

2.5

6.5

164

J01FA10

ATC

azithromycin; systemic

1.2

6.5

1456

13033

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.0

6.5

347

IHZ05, ,

SPAT

1.9

6.5

375

XF402

NOMESCO Finland

ECG with work load test

1.4

6.5

306

2265

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

6.5

140

885

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.5

6.5

167

1100

A10BB01

ATC

glibenclamide; oral

1.6

6.5

154

996

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

6.5

240

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

6.2

6.5

162

Kela drug reimbursment

liraglutide

2.6

6.5

135

H26.02

ICD-10 Finland

Presenil cataract

2.0

6.5

341

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

1.9

6.5

404

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.6

6.4

151

973

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

6.4

206

1420

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

1.9

6.4

376

C09CA03

ATC

valsartan; oral

1.4

6.4

279

2035

ZPB40

NOMESCO Finland

Polytetrafluoroethylene

3.9

6.4

TPX15

NOMESCO Finland

Removal of vascular injection port

3.9

6.4

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.7

6.4

107

632

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

14.3

6.4

H57.1

ICD-10 Finland

Ocular pain

1.8

6.4

536

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

6.4

434

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.4

199

1365

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.0

6.4

322

L04AA11

ATC

[U] etanercept

4.1

6.3

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.1

6.3

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

4.1

6.3

R03BA01

ATC

beclometasone; inhalant

1.3

6.3

386

2973

L40.8

ICD-10 Finland

Other psoriasis

3.0

6.3

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.0

6.3

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.0

6.3

309

WW409

NOMESCO Finland

Other aferesis

8.2

6.3

NF3AA

NOMESCO Finland

Femur X-ray examination

1.9

6.3

414

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.3

218

1526

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.2

6.3

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.3

592

4832

R77.8

ICD-10 Finland

Other specified abnormalities of plasma proteins

11.0

6.3

L95.8

ICD-10 Finland

Other vasculitis limited to skin

5.5

6.3

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

3.2

6.3

K59.0

ICD-10 Finland

Constipation

1.5

6.3

177

1189

YNB10

NOMESCO Finland

Collection of stem cells for transplant

9.3

6.3

SPAT1088

SPAT

Blood transfusion

3.3

6.3

3025

Kela drug reimbursment

Calcium carbonate

3.3

6.3

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.3

6.3

R5110, ,

SPAT

1.4

6.3

278

2037

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.7

6.2

577

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.6

6.2

144

925

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.7

6.2

120

R52.9

ICD-10 Finland

Pain, unspecified

1.4

6.2

276

2021

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

6.2

638

5263

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

6.2

199

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.4

6.2

174

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

6.2

510

4094

D09AB01

ATC

zinc bandage without supplements; topical

2.0

6.2

298

A10BX07

ATC

[U] liraglutide

2.5

6.2

150

G44.2

ICD-10 Finland

Tension-type headache

1.4

6.2

336

2544

D11

ICPC

Diarrhoea

1.4

6.2

284

2093

R41.0

ICD-10 Finland

Disorientation, unspecified

1.7

6.2

108

647

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.0

6.2

N07BB01

ATC

disulfiram; oral

1.9

6.2

425

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

6.3

6.2

R13

ICD-10 Finland

Dysphagia

1.5

6.1

213

1492

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.9

6.1

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

2.8

6.1

104

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

5.3

6.1

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.2

6.1

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.3

6.1

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.3

6.1

194

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.6

6.1

133

OAB72, ,

SPAT

2.6

6.1

133

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.7

6.1

110

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.7

6.1

110

665

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.1

1479

13313

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.8

6.1

427

CKC12

NOMESCO Finland

Photocoagulation of retina

1.7

6.1

106

635

N05BA04

ATC

oxazepam; oral

1.2

6.1

765

6457

R51.81

ICD-10 Finland

Facial pain NOS

2.0

6.1

328

XKD00

NOMESCO Finland

Uroflowmetry

1.3

6.1

434

3420

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

6.1

131

829

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

2.8

6.0

105

J01DA09

ATC

[U] cefadroxil

1.2

6.0

695

5807

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

3.1

6.0

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

10.0

6.0

N05AX12

ATC

aripiprazole; systemic

1.9

6.0

350

M54

ICD-10 Finland

Dorsalgia

1.4

6.0

294

2189

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

2.7

6.0

111

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.7

6.0

111

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

6.0

130

823

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.5

6.0

J01CA08

ATC

pivmecillinam; oral

1.2

6.0

1167

10287

H3601, E113,

ICD-10 Finland

2.2

6.0

228

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

629

1208

6.17

322.13

3.8

2.3

1.75

0.99

g/l

2.42

523

1012

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

507

787

7.40

319.79

2.0

1.4

1.31

1.18

g/l

11.34

481

757

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

431

481

10.12

307.65

1.6

1.4

9.59

15.82

u/ml

0.37

(3009445) Proteinase 3 Ab [Units/volume] in Serum

815

1192

8.69

307.65

1.7

1.5

6.48

23.09

iu/ml

1.29

(3020630) Protein [Mass/volume] in Serum or Plasma

1432

2879

7.89

307.65

3.7

2.6

68.85

65.95

g/l

27.28

1325

2601

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

636

1227

6.15

307.65

3.3

2.3

12.06

10.19

g/l

10.69

572

1069

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

772

1407

6.81

307.65

3.4

2.2

4.49

4.19

g/l

5.90

718

1260

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1226

3847

4.43

307.65

4.2

4.1

225.58

248.75

u/l

6.24

1158

3620

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

505

762

7.62

307.65

2.0

1.4

0.25

0.24

g/l

2.02

480

732

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

772

1408

6.81

307.65

3.4

2.2

8.34

7.41

g/l

30.56

718

1260

(3037756) Immunofixation for Serum or Plasma

647

701

11.18

307.65

1.7

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

876

1031

11.12

307.65

3.2

3.1

2.91

3.65

ratio

0.32

527

622

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

653

1129

6.93

307.65

1.8

37.30

38.68

u/l

0.75

576

984

(3034860) Kappa light chains.free [Mass/volume] in Serum

969

1150

11.41

307.65

3.4

3.3

49.57

102.33

mg/l

0.58

765

980

(3028026) IgM [Mass/volume] in Serum or Plasma

914

1569

7.61

307.65

3.4

1.9

2.30

1.43

g/l

5.15

848

1420

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

712

1311

6.61

307.65

3.5

2.3

3.13

2.95

g/l

3.20

658

1164

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

681

1012

8.17

307.65

1.5

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1011

2021

6.71

307.65

3.9

2.8

12.02

10.60

g/l

8.90

947

1851

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

969

1147

11.44

307.65

3.4

3.3

44.02

45.94

mg/l

0.13

767

980

(3037522) Nuclear Ab [Titer] in Serum

1350

3528

5.70

307.65

1.6

1.3

571.90

511.09

titre

0.56

373

808

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

771

1406

6.81

307.65

3.4

2.2

4.37

3.63

g/l

11.47

715

1260

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

482

689

7.99

307.65

1.7

2.0

12.43

12.31

mg/l

0.07

442

628

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

409

534

8.58

299.50

1.4

1.2

146.67

290.91

titre

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

544

980

6.42

296.47

1.3

1.2

0.25

0.70

u/ml

0.89

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

407

535

8.51

296.29

1.4

1.2

439.47

306.25

titre

0.41

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

488

803

6.93

290.51

1.6

1.5

0.32

1.03

iu/ml

0.37

161

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1252

4737

3.61

263.04

3.6

2.7

19.31

21.59

7.94

1169

4354

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

519

1001

5.94

262.32

3.3

2.2

0.07

0.02

g/l

0.75

438

891

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1313

5136

3.54

261.58

3.6

2.6

2.17

2.27

g/l

8.07

1222

4698

(3022948) Iron [Moles/volume] in Serum or Plasma

1363

5481

3.49

259.48

3.6

2.6

10.23

12.24

umol/l

26.16

1275

5055

(3027945) Reticulocytes/Erythrocytes in Blood

1123

4047

3.66

252.93

2.9

2.4

1.80

1.81

0.08

1016

3556

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

436

763

6.41

243.01

1.7

1.4

11.91

18.74

iu/ml

0.47

(3023520) Reticulocytes [#/volume] in Blood

941

3145

3.76

235.53

3.3

2.4

67.85

68.41

e9/l

0.17

730

2310

(3023420) DNA double strand Ab [Units/volume] in Serum

513

1080

5.42

234.57

2.3

1.6

7.19

7.48

iu/ml

0.07

151

242

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

483

965

5.67

234.04

3.3

2.2

0.00

g/l

0.50

378

844

(3001604) Monocytes [#/volume] in Blood

2440

14613

3.40

226.55

11.3

5.9

0.65

0.60

e9/l

16.26

2253

12360

(3006315) Basophils [#/volume] in Blood

2445

14666

3.41

226.30

11.4

5.9

0.04

e9/l

0.99

2262

12406

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1167

4579

3.36

225.99

1.4

1.3

11.99

13.59

u/ml

0.27

405

1657

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1203

4897

3.26

217.91

1.4

1.3

56.73

35.33

iu/ml

1.62

412

1493

(3019069) Monocytes/Leukocytes in Blood

2307

13569

3.20

216.73

12.0

6.2

8.93

9.02

0.70

2221

12615

(3019198) Lymphocytes [#/volume] in Blood

2449

14927

3.32

215.80

11.6

6.0

1.78

1.88

e9/l

2.88

2292

12945

(3013115) Eosinophils [#/volume] in Blood

2468

15113

3.34

215.69

11.7

6.1

0.19

e9/l

0.07

2306

12978

(3006504) Eosinophils/Leukocytes in Blood

2296

13550

3.16

212.72

11.8

6.1

2.58

2.82

6.11

2216

12603

(3022096) Basophils/Leukocytes in Blood

2294

13549

3.15

211.88

12.1

6.2

0.64

0.66

1.08

2209

12595

(3007164) IgA [Mass/volume] in Serum or Plasma

1229

5171

3.16

208.95

2.4

1.5

3.32

2.53

g/l

13.47

959

2955

(21494890) Protein electrophoresis panel - 24 hour Urine

265

318

8.96

206.40

1.8

2.1

—

(3002030) Lymphocytes/Leukocytes in Blood

2307

13794

3.12

205.93

11.9

6.2

24.30

26.60

21.48

2241

12998

(3018010) Neutrophils/Leukocytes in Blood

2273

13536

3.07

203.25

11.6

6.1

61.13

58.15

28.06

2208

12844

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

597

1640

4.21

194.72

1.8

1.7

2.00

1.53

g/l

16.21

508

1408

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1675

8694

2.84

189.74

3.3

2.4

3.05

2.94

mg/l

1.29

1516

7427

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

421

902

5.19

187.18

3.6

2.3

0.00

g/l

-0.00

375

843

(3017704) Immunofixation for Urine

193

171

11.91

186.80

1.5

1.7

—

(3044927) Protein electrophoresis panel - Urine

263

353

7.99

186.51

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

264

384

7.37

174.28

1.8

1.6

0.95

0.79

g/l

0.74

187

301

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

518

1411

4.15

169.71

2.5

1.8

1.17

1.98

ug/l

1.32

448

1214

(3013650) Neutrophils [#/volume] in Blood by Automated count

2500

16516

2.97

169.46

15.0

9.2

4.68

4.21

e9/l

20.35

2317

14229

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1000

4238

2.93

161.42

7.7

5.5

1.08

1.04

mmol/l

4.62

943

3895

(3024561) Albumin [Mass/volume] in Serum or Plasma

2227

14089

2.70

159.98

8.2

4.9

33.10

34.96

g/l

44.67

2118

13093

(3026493) Urate [Moles/volume] in Serum or Plasma

1467

7670

2.61

155.65

3.8

2.8

358.07

350.01

umol/l

1.77

1304

6605

(3017181) Myelocytes/Leukocytes in Blood

732

2717

3.16

148.19

6.7

4.1

0.82

0.90

0.43

304

847

(3024139) IgG subclass 3 [Mass/volume] in Serum

190

233

8.58

144.85

1.7

1.4

0.47

0.42

g/l

0.61

126

169

(3027135) IgG subclass 1 [Mass/volume] in Serum

190

233

8.58

144.85

1.7

1.4

8.13

6.80

g/l

1.96

124

169

(3028192) IgG subclass 2 [Mass/volume] in Serum

190

233

8.58

144.85

1.7

1.4

3.22

2.96

g/l

0.73

125

169

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2391

16094

2.66

143.94

12.5

7.1

1.21

mmol/l

0.61

2046

13768

(3002179) Metamyelocytes/Leukocytes in Blood

703

2590

3.16

143.77

6.4

4.0

0.49

0.71

2.44

284

806

(46235355) HIV 1 and 2 tests - Meaningful Use set

866

3597

2.89

142.92

1.7

—

(4062490) Immunoglobulin typing, IgG

188

232

8.52

142.58

1.7

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

232

373

6.60

139.03

2.4

2.2

1.05

1.31

g/24h

0.54

139

216

(3021440) Promyelocytes/Leukocytes in Blood

690

2598

3.08

135.23

6.9

4.2

0.07

0.10

0.77

258

734

(40760892) CBC W Ordered Manual Differential panel - Blood

1188

5941

2.54

134.15

8.9

4.7

—

(3023368) Bacteria identified in Blood by Culture

1620

9338

2.41

133.55

6.9

4.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

699

2696

3.01

130.93

2.5

2.2

349.65

385.80

nmol/l

5.01

649

2469

(3025159) Blasts/Leukocytes in Blood

685

2615

3.03

130.66

7.3

4.3

0.16

0.12

0.16

243

689

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2046

13170

2.40

129.62

4.9

3.1

207.54

131.88

ug/l

13.93

1925

12091

(3042111) Morphology [Interpretation] in Bone marrow Narrative

266

531

5.35

127.03

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2157

14483

2.35

119.87

10.1

6.4

1.21

mmol/l

0.30

2040

13244

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

285

639

4.78

118.69

1.3

1.2

1.51

4.47

u/ml

0.89

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2298

15921

2.38

117.67

8.7

6.4

9.81

11.93

umol/l

22.52

2211

15117

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

309

748

4.45

116.89

1.4

1.2

10.97

3.57

u/ml

0.61

(3018418) pH of Serum or Plasma

1611

9701

2.26

114.56

7.0

4.1

7.40

0.41

1316

7015

(3017143) Hepatitis C virus Ab [Presence] in Serum

633

2482

2.91

113.79

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

305

750

4.37

112.98

1.4

1.2

11.25

7.24

u/ml

0.42

115

(3007566) Smooth muscle Ab [Titer] in Serum

274

627

4.67

111.15

1.2

1.1

136.94

90.89

titre

0.59

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

246

516

5.06

110.77

4.5

4.8

146.00

632.73

iu/ml

0.96

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

311

793

4.22

109.75

1.4

1.2

34.60

42.64

u/ml

0.17

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

167

250

6.98

106.81

1.7

1.8

3.57

4.52

mg/l

2.45

158

242

(3037121) Protein [Mass/volume] in Urine

368

1095

3.65

104.24

2.8

3.1

322.86

389.43

mg/l

0.43

197

431

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

314

839

4.02

103.85

1.8

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

690

2971

2.66

102.71

9.7

6.6

12.31

10.76

mmol/l

5.36

663

2821

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1591

9843

2.16

102.17

2.8

2.2

158.00

209.57

u/l

2.09

1518

9255

(3034770) Mitochondria Ab [Titer] in Serum

265

636

4.44

101.07

1.2

793.85

1398.82

titre

0.67

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1553

9553

2.16

100.82

3.3

2.6

54.31

69.01

u/l

1.07

1455

8793

(3019309) Folate [Moles/volume] in Red Blood Cells

1121

6127

2.24

97.35

2.2

1.8

1266.22

1161.68

nmol/l

2.62

881

4575

(3026782) Osmolality of Urine

1119

6120

2.24

96.95

3.8

3.0

490.05

520.63

mosm/kgh2o

5.78

1021

5340

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

370

1157

3.47

96.90

3.2

2.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

706

3177

2.54

95.30

1.7

1.6

—

(3042936) Bacteria identified in Isolate by Culture

873

4401

2.33

91.08

2.7

2.0

—

(3000012) Reticulocyte production index

223

509

4.62

90.46

2.9

2.0

0.86

0.87

0.09

172

346

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

577

2426

2.66

89.07

2.0

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

197

413

5.00

88.52

2.6

2.5

2662.86

1279.61

u/ml

0.27

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1062

5861

2.18

88.48

2.6

1.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

169

319

5.52

85.47

1.4

1.2

44.50

64.04

u/ml

—

(3000850) Epithelial cells [#/volume] in Urine

1209

7093

2.10

85.28

3.7

2.7

5.73

5.72

e6/l

0.00

1134

6445

(3021960) Folate [Moles/volume] in Serum or Plasma

1510

9637

2.02

84.23

2.2

1.7

19.62

20.42

nmol/l

1.13

1338

8053

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

596

2618

2.55

83.71

4.7

3.7

96.71

92.28

ng/l

0.48

512

2199

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2686

21171

2.31

83.35

12.0

4.4

37.53

13.61

mm/h

294.48

2569

19561

(3012095) Magnesium [Moles/volume] in Serum or Plasma

968

5267

2.17

82.66

3.5

3.1

0.80

0.82

mmol/l

2.54

915

4907

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

200

453

4.63

81.81

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

113

154

7.56

78.53

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

270

790

3.63

77.86

2.1

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

188

428

4.59

76.37

1.3

1.2

—

124.30

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

194

461

4.40

74.63

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

268

811

3.50

73.33

2.1

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

419

1649

2.76

72.84

1.5

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1898

13585

1.91

71.13

3.3

2.4

79.73

79.35

nmol/l

0.22

1759

12010

(3037467) Urinalysis macro (dipstick) panel - Urine

2536

20014

2.07

71.09

7.9

5.0

3.41

2.58

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

176

405

4.53

70.50

1.2

1.1

4.64

10.19

u/ml

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2742

22316

2.21

70.36

15.1

8.2

87.58

80.88

u/l

9.26

2678

21007

(3030467) Casts [#/volume] in Urine by Automated count

1350

8686

1.92

69.86

4.6

3.4

0.44

0.51

e6/l

0.55

1149

6445

(3002582) Erythrocytes [#/volume] in Urine

1509

10071

1.90

69.78

4.7

3.5

71.29

85.82

e6/l

0.24

1298

7751

(3001686) Cold agglutinin [Titer] in Serum or Plasma

11.87

69.71

1.4

1.2

378.67

128.22

titre

—

(3017732) Neutrophils [#/volume] in Blood

712

3640

2.21

69.56

4.1

3.2

5.98

4.56

e9/l

0.88

616

3054

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

172

395

4.53

69.06

1.3

1.2

307.59

269.43

u/ml

0.76

102

229

(3032080) INR in Blood by Coagulation assay

2033

14969

1.90

68.81

22.6

18.1

1.32

1.33

inr

0.27

1816

12576

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

209

559

3.92

68.53

1.4

1.2

48.30

46.34

u/ml

0.05

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

565

2646

2.36

67.89

6.0

3.8

1.22

1.23

mmol/l

0.73

518

2260

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

652

3.68

67.88

1.9

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

184

464

4.14

65.39

1.9

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

214

612

3.67

63.65

1.3

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

490

2213

2.42

63.62

5.3

3.7

5.16

5.15

kpa

0.02

472

2099

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

614

3065

2.23

63.04

2.5

2.1

0.19

0.20

g/l

3.38

567

2851

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

166

401

4.30

62.43

1.4

156.12

161.67

au/ml

0.17

117

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1544

10690

1.82

60.85

4.2

3.3

2341.18

1667.79

ng/l

3.85

1367

9338

(36304419) Bacteria [Presence] in Urine

1261

8206

1.86

60.84

4.5

3.3

0.00

313.39

estimate

0.61

(3009343) pH of Capillary blood

474

2152

2.40

60.66

5.2

3.7

7.41

7.42

0.88

402

1789

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

199

560

3.71

60.58

1.8

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

556

3.72

60.46

1.8

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

207

600

3.61

60.31

4.3

3.3

60.43

58.42

1.26

207

600

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1926

14277

1.81

60.14

2.7

2.3

94.72

94.97

pmol/l

0.08

1163

7391

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

782

4365

2.03

59.58

2.4

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

196

555

3.69

59.11

2.0

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1575

11067

1.79

58.23

4.0

3.5

2.34

2.36

mmol/l

5.45

1436

9918

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1351

9131

1.80

56.47

4.0

3.0

35.52

37.11

u/l

0.21

1272

8581

(3035350) Ketones [Presence] in Urine by Test strip

2032

15506

1.78

55.46

6.3

4.3

2.34

4.07

estimate

0.28

634

3434

(3018095) Leukocytes [#/volume] in Urine

1587

11294

1.76

55.16

5.8

4.1

123.61

116.77

e6/l

0.09

1325

8036

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

730

4075

2.01

55.09

2.5

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

128

279

4.73

54.75

1.3

1.2

56.05

62.17

u/l

0.41

118

241

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

248

853

3.06

54.73

3.4

2.9

1.87

1.68

mg/l

2.22

226

749

(3013826) Glucose [Moles/volume] in Serum or Plasma

2264

17870

1.81

54.66

7.9

5.0

7.00

6.77

mmol/l

5.32

2180

17006

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

420

1896

2.39

54.12

5.1

3.6

2.04

2.00

mmol/l

0.07

318

1381

(1616796) Gas panel - Central venous blood

225

742

3.18

53.34

5.5

3.8

—

(21494434) Karyotype in Bone marrow

124

270

4.73

53.11

1.1

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

2001

15305

1.75

53.10

6.3

4.2

0.00

estimate

0.26

624

3313

(3048689) Calprotectin [Mass/mass] in Stool

621

3310

2.07

53.04

2.4

2.2

198.53

149.69

ug/g

1.51

510

2593

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

218

711

3.21

52.63

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

250

884

2.97

52.51

1.8

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

130

300

4.47

51.81

1.3

1.1

51.29

47.11

u/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

237

822

3.03

51.50

1.8

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2025

15623

1.74

51.28

6.4

4.3

0.00

0.10

estimate

0.54

602

3223

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

966

6044

1.84

51.04

1.4

1.3

2.31

1.58

u/ml

0.65

256

1540

(3015235) Bicarbonate [Moles/volume] in Capillary blood

299

1184

2.67

50.72

3.8

3.0

24.85

24.91

mmol/l

0.09

294

1162

(3045142) Bone marrow Pathology biopsy report

137

338

4.18

50.07

1.2

1.3

—

(3011412) CD3 cells [#/volume] in Blood

112

237

4.85

49.64

2.6

2.0

1170.99

1096.91

e6/l

0.34

105

212

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

151

403

3.88

49.55

1.8

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

644

3562

2.00

49.30

2.3

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

141

362

4.02

48.83

1.5

1.2

—

(3021589) Normoblasts [#/volume] in Blood

1688

12494

1.70

48.75

24.3

12.0

0.00

e9/l

1.22

1469

10104

(3031040) Bacteria [#/volume] in Urine by Automated count

2397

19664

1.75

45.98

7.4

5.3

969.80

2614.68

e6/l

1.79

300

(3004809) Band form neutrophils/Leukocytes in Blood

175

544

3.34

45.64

3.3

3.8

0.95

1.55

2.16

161

475

(3027801) Oxygen [Partial pressure] in Arterial blood

672

3872

1.92

45.24

7.6

6.9

11.31

12.07

kpa

3.68

645

3716

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

671

3873

1.91

44.90

7.7

6.9

5.06

5.10

kpa

0.46

645

3713

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

151

5.68

44.69

1.5

1.4

6.01

6.93

u/l

0.35

131

(3019977) pH of Arterial blood

669

3867

1.91

44.53

7.7

7.0

7.42

0.11

430

2139

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

293

1225

2.52

44.32

2.0

2.1

244.66

700.36

ug/l

1.90

275

1159

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

135

5.97

44.30

2.1

1.7

40.32

39.53

g/l

0.54

135

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

10.34

44.01

1.5

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1165

7973

1.70

43.71

5.7

3.7

0.05

0.26

estimate

0.86

539

2598

(3026008) Bacteria identified in Urine by Culture

1448

10493

1.66

43.70

4.8

3.5

—

(40761536) Microorganisms panel - Urine sediment

464

2378

2.10

43.37

6.8

4.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

105

6.69

43.35

1.4

1.3

1.66

0.34

g/l

—

(40768797) Stomach Pathology biopsy report

695

4111

1.87

42.90

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

141

398

3.65

42.65

2.0

1.5

—

(3003396) Base excess in Arterial blood by calculation

660

3849

1.89

42.55

7.6

6.9

1.07

1.02

mmol/l

0.11

535

3142

(1175426) CD3 cells/Lymphocytes in Blood

183

5.03

41.80

2.4

1.9

73.39

71.01

0.69

169

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1027

6859

1.71

41.76

2.1

1.8

7981688.93

24222261.38

pmol/l

0.99

852

5590

(3020682) Albumin/Creatinine [Ratio] in Urine

1425

10381

1.64

41.45

5.4

4.1

23.65

9.12

mg/mmol

8.26

990

6383

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

177

5.08

41.39

2.3

1.9

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

129

350

3.79

41.34

1.7

1.6

60.82

62.93

0.23

222

(3010838) Calcium [Moles/time] in 24 hour Urine

161

507

3.28

41.10

1.5

1.9

4.21

4.69

mmol/24h

1.13

141

429

(3012516) Albumin [Mass/volume] in Urine

1396

10149

1.64

40.73

4.4

3.4

111.21

47.12

mg/l

9.05

999

6420

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

172

5.10

40.71

2.2

2.0

14.90

15.88

0.30

165

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

137

5.65

40.33

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

101

233

4.44

40.28

1.3

1.1

37.13

44.94

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

157

5.26

39.72

1.1

1.2

93.15

77.33

u/l

1.52

136

(3018677) aPTT in Platelet poor plasma by Coagulation assay

781

4889

1.78

39.63

2.6

2.0

30.64

29.78

2.64

761

4741

(3015736) pH of Urine

1621

12287

1.61

39.49

5.0

3.8

6.26

6.28

0.28

917

6673

(3008898) HLA-B27 [Presence]

193

694

2.89

39.19

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1421

10457

1.62

38.94

4.3

3.4

6.57

7.02

mmol/l

4.11

1237

8696

(3042631) Mycobacterium sp identified in Specimen

146

450

3.35

38.58

3.0

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

341

1618

2.23

38.56

1.5

1.3

290.19

231.96

u/ml

0.64

320

1495

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2118

17178

1.62

38.56

5.0

3.3

69.05

51.41

u/l

9.10

1994

15809

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

189

678

2.89

38.55

1.8

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

115

303

3.89

38.42

1.2

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

12.89

38.32

1.6

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

152

485

3.23

37.97

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1231

8794

1.63

37.75

6.8

4.4

0.00

estimate

1.34

574

3007

(3016502) Oxygen saturation in Arterial blood

589

3434

1.87

37.56

7.9

7.2

95.05

95.35

0.53

568

3321

(3021447) Carbon dioxide [Partial pressure] in Venous blood

586

3411

1.87

37.55

6.0

3.3

5.81

5.83

kpa

0.19

576

3318

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

154

5.16

37.48

2.8

2.0

201.69

221.32

e6/l

0.31

137

(3023183) Ammonium ion [Moles/volume] in Plasma

177

627

2.92

36.93

2.7

31.92

35.42

umol/l

0.85

159

561

(3000475) Leukocytes [#/volume] in Synovial fluid

205

786

2.71

36.86

2.1

1.6

11576.42

14562.03

e6/l

0.69

153

542

(3003329) Lymphocytes/Leukocytes in Synovial fluid

104

263

4.05

36.78

1.7

1.5

31.11

29.53

0.17

166

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

157

5.06

36.67

1.2

25.18

24.04

u/l

0.09

137

(3012544) pH of Venous blood

585

3429

1.85

36.59

6.2

3.4

7.38

0.50

408

1996

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

241

4.16

35.98

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

187

4.64

35.97

1.2

227.00

165.59

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

156

5.03

35.93

2.6

1.9

545.74

477.02

e6/l

0.37

128

(3002032) Base excess in Venous blood by calculation

567

3313

1.85

35.75

6.0

3.4

1.57

1.90

mmol/l

1.32

500

2854

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

940

6344

1.67

35.70

2.0

1.7

1.71

1.44

mg/l

0.81

780

4938

(3012501) Base excess in Blood by calculation

183

673

2.82

35.63

5.7

4.6

2.55

2.82

mmol/l

0.65

136

472

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

565

3302

1.85

35.59

5.1

3.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

102

261

4.00

35.50

2.0

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

360

1803

2.12

35.41

2.5

22.16

21.69

au/ml

0.03

148

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

215

4.32

35.21

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

208

4.37

34.93

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

196

4.48

34.84

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

204

4.35

34.00

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

204

4.35

34.00

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

221

915

2.51

33.98

1.5

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1499

11435

1.56

33.61

6.5

4.3

0.02

0.46

estimate

1.03

545

2711

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

177

665

2.75

33.08

1.5

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

254

1134

2.34

33.06

1.4

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

193

4.38

32.79

1.2

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1573

12194

1.54

32.39

6.3

4.2

52.95

101.01

ng/l

0.76

1292

9288

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

200

4.28

32.20

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

6.22

31.78

1.7

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

204

4.20

31.38

2.0

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

183

4.40

31.37

2.1

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

325

1640

2.09

31.21

1.3

47.77

52.32

au/ml

0.12

119

(3023419) Bacteria identified in Sputum by Culture

130

425

3.14

31.20

2.5

—

(3017354) Segmented neutrophils/Leukocytes in Blood

116

354

3.36

31.16

3.2

3.6

59.61

58.36

0.25

104

298

(44790049) Parainfluenza type 3 nucleic acid detection

120

375

3.28

31.03

1.9

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

120

375

3.28

31.03

1.9

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

120

375

3.28

31.03

1.9

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

120

375

3.28

31.03

1.9

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

532

3173

1.80

31.02

8.7

7.6

112.84

119.63

g/l

13.30

522

3102

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

108

317

3.49

30.83

1.9

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

232

3.91

30.22

1.8

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

164

4.53

30.13

1.6

1.5

5.12

5.85

u/l

0.17

129

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

126

5.08

29.86

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

106

314

3.45

29.84

1.0

1.1

1.68

1.55

g/l

2.13

100

283

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

481

2818

1.82

29.66

4.4

3.2

289.08

235.22

ng/l

1.50

449

2585

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

550

3355

1.76

29.60

2.9

2.6

7.02

8.74

umol/l

1.97

460

2963

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

153

4.58

28.95

2.9

2.5

43.83

39.91

0.86

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

178

4.29

28.89

2.1

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

162

626

2.67

28.66

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

251

3.70

28.52

1.9

1.5

13.49

13.33

u/l

0.07

240

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

160

4.45

28.29

1.4

1.2

125.65

81.02

u/l

1.64

131

(3012565) Volume of 24 hour Urine

134

4.77

27.81

3.4

2.5

2000.61

1898.05

0.30

113

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

297

3.40

27.34

1.9

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

126

442

2.92

26.77

7.1

6.4

12.99

12.48

mg/l

0.52

120

417

(3022313) Gas panel - Capillary blood

294

1519

2.02

26.36

5.4

3.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

109

357

3.12

26.11

1.1

—

(3045424) Erythrocytes [Presence] in Urine

289

1491

2.03

26.01

2.6

2.2

0.01

0.59

estimate

0.49

423

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

156

4.30

25.58

1.4

1.2

26.58

19.42

u/l

0.86

125

(3019832) Treponema pallidum Ab [Presence] in Serum

300

1582

1.98

25.37

1.5

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

181

785

2.38

25.11

3.3

2.3

4.15

3.62

g/l

3.49

169

745

(3022145) Colonoscopy Study observation

522

3278

1.70

24.99

1.4

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

364

2058

1.86

24.96

7.2

6.4

24.34

24.49

mmol/l

0.28

353

1971

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1689

13771

1.45

24.41

4.1

2.9

—

estimate

—

(21494814) CD8 cells/Lymphocytes in Specimen

103

5.01

23.94

2.3

2.0

31.14

29.65

0.24

103

(3006184) Hemoglobin [Mass/volume] in Capillary blood

183

817

2.31

23.76

3.5

2.2

120.17

127.34

g/l

4.23

155

641

(3047181) Lactate [Moles/volume] in Blood

205

961

2.21

23.68

6.9

5.6

1.41

1.32

mmol/l

0.52

187

854

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

924

6725

1.51

23.62

3.2

3.1

2.50

2.46

mmol/l

11.30

832

6009

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.63

23.49

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.63

23.49

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.63

23.49

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

5.63

23.49

1.1

1.0

—

(3016750) Collection duration of Urine

159

4.08

23.26

2.3

2.1

499.63

496.86

min

0.07

121

(3000991) Gas panel - Venous blood

455

2809

1.72

23.07

10.6

7.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

178

3.88

23.01

1.2

1.1

—

titre

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

152

4.14

22.93

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

221

3.54

22.80

1.5

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

145

596

2.50

22.63

1.2

1.1

2.57

3.62

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

278

1488

1.95

22.46

6.3

4.8

1.66

1.57

0.94

267

1407

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

205

3.62

22.34

2.2

1.8

—

(3004775) Volume in Urine collected for unspecified duration

222

3.48

21.92

2.3

2.2

729.60

628.54

1.08

145

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

7.75

21.67

1.1

1.5

13.90

254843.10

nmol/l

0.49

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2425

21401

1.47

21.59

5.5

4.5

15.12

15.00

pmol/l

1.52

2242

19277

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

173

3.81

21.50

1.7

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

173

3.81

21.50

1.7

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

189

892

2.19

21.47

1.7

1.6

0.34

0.32

mg/l

0.18

392

(3047007) Chlamydophila sp Ab [Presence] in Serum

302

3.07

21.36

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

468

2981

1.66

20.99

8.2

6.6

1.39

1.35

mmol/l

0.29

459

2927

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

106

387

2.80

20.97

1.1

1.0

—

(3006245) CD3-CD19+ cells/cells in Blood

5.38

20.88

2.3

1.9

8.69

10.48

0.36

(3000570) Elastase.pancreatic [Mass/mass] in Stool

195

942

2.14

20.88

1.4

1.5

271.00

270.14

ug/g

0.02

112

565

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

350

2.88

20.79

1.4

388.71

326.17

u/l

0.42

333

(40758558) Short blood count panel - Blood

1135

8776

1.44

20.79

9.0

6.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

261

3.19

20.66

2.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

261

3.19

20.66

2.0

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

261

3.19

20.66

2.0

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

130

535

2.49

20.25

1.6

1.5

31.20

31.44

g/l

0.07

120

490

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

292

1647

1.85

20.05

2.8

3.4

4.24

4.43

pmol/l

2.23

254

1455

(3044640) Blood type and Crossmatch panel - Blood

1253

9924

1.42

19.85

3.7

2.5

—

(4268621) Lupus anticoagulant assay

242

3.23

19.82

3.0

2.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

223

3.32

19.67

1.4

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

348

2087

1.74

19.44

5.1

2.9

115.84

127.90

g/l

20.09

339

2025

(3019225) pH of Specimen

495

3256

1.61

19.42

7.6

4.5

7.36

0.09

417

2274

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

5.25

19.37

2.3

1.9

29.53

27.91

0.25

(3024354) Oxygen [Partial pressure] in Venous blood

446

2862

1.64

19.34

4.9

2.9

4.50

4.46

kpa

0.17

432

2780

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

222

1158

1.98

19.31

3.7

2.9

0.34

0.35

iu/ml

0.16

131

646

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

226

3.28

19.26

1.4

1.3

—

(3034891) Synovial lining cells/cells in Synovial fluid

142

3.92

19.01

1.6

1.4

2.60

4.42

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

334

2.83

19.00

3.3

3.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

249

1361

1.90

18.85

2.7

1.9

—

(3000494) Fungus identified in Specimen by Culture

519

3478

1.58

18.78

1.7

1.4

—

(3045414) Leukocytes [Presence] in Urine

457

2979

1.62

18.56

2.5

2.2

0.04

0.01

estimate

0.34

109

552

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

222

1177

1.95

18.42

6.0

3.9

24.86

24.88

mmol/l

0.03

207

1068

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

128

548

2.39

18.32

1.3

1.2

79.77

42.71

u/l

0.91

112

472

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

277

2.97

18.09

1.4

1.3

13.21

12.70

u/l

0.09

256

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

310

1835

1.76

18.09

10.8

9.3

14.97

15.77

6.22

302

1770

(3007930) Methemoglobin/Hemoglobin.total in Blood

248

1374

1.87

18.00

6.7

5.0

0.86

0.12

237

1299

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

376

2.65

17.67

1.3

366.62

305.65

pmol/l

0.67

318

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

174

3.49

17.56

4.5

3.8

—

(3003181) Sodium [Moles/volume] in Urine

146

675

2.22

17.48

1.5

1.4

56.97

62.51

mmol/l

1.01

117

541

(3036071) Salmonella sp Ab [Titer] in Serum

5.27

17.01

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

343

2.70

17.00

1.6

1.2

9.21

3.50

u/ml

1.38

111

(3033658) Prothrombin time (PT) actual/Normal

971

7539

1.40

16.55

5.7

4.0

86.81

86.64

0.07

945

7363

(3036782) Glucose [Moles/volume] in Pleural fluid

380

2.57

16.28

1.5

1.4

6.87

6.46

mmol/l

0.55

363

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

241

2.99

16.10

2.8

2.4

15.65

37.55

iu/ml

1.33

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

285

1704

1.73

16.03

2.6

2.5

—

(3011985) Renin [Units/volume] in Plasma

100

407

2.50

16.01

1.8

1.4

82.74

65.98

mu/l

0.26

362

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

225

1260

1.84

15.78

2.5

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

320

1987

1.67

15.65

9.2

8.4

24.32

24.27

mmol/l

0.10

304

1939

(3039000) Anion gap in Blood by calculation

136

641

2.17

15.55

8.1

6.7

11.58

11.26

mmol/l

0.46

126

575

(3012441) Differential panel - Pleural fluid

401

2.49

15.52

1.7

1.5

—

(3018572) Chloride [Moles/volume] in Blood

136

642

2.17

15.49

8.1

6.7

104.12

105.14

mmol/l

1.41

126

576

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

337

2.62

15.43

3.7

3.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

142

683

2.13

15.42

2.8

2.3

207.56

96.03

ug/min

1.24

408

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

411

2.45

15.21

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

373

2428

1.60

15.10

1.8

1.7

1.68

1.53

3.37

306

2073

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

413

2.44

15.06

1.7

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

288

1759

1.70

14.98

1.6

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

427

2874

1.56

14.97

3.1

2.4

6.42

6.79

ug/l

0.15

368

2467

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

275

1659

1.72

14.96

1.2

104.88

142.60

u/ml

1.15

595

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

4.06

14.96

2.0

2.1

451.29

29976.38

u/ml

—

(40768441) Liver Pathology biopsy report

178

3.24

14.90

1.4

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

286

2.73

14.84

1.2

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

999

7919

1.37

14.67

4.2

3.3

0.41

0.05

1.44

270

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

503

3523

1.50

14.64

3.0

4.1

9.31

19.06

ug/l

1.58

406

2894

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

813

6236

1.40

14.56

5.9

4.2

184.55

331.74

ng/l

2.40

697

5217

(3003327) Ova and parasites identified in Stool by Light microscopy

165

857

1.97

14.55

1.8

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

408

2.42

14.50

1.7

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.99

14.31

1.1

23.58

24.07

u/l

0.03

(3023383) Lactate [Moles/volume] in Pleural fluid

111

3.82

14.12

1.3

1.4

3.32

3.33

mmol/l

0.01

101

(3035880) pH of Pleural fluid

212

2.96

13.93

1.3

7.35

7.40

0.61

152

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

127

609

2.13

13.93

1.2

1.4

74.30

36.60

e6/l

0.52

100

457

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

128

616

2.12

13.91

1.3

1.5

17176.04

850.61

e6/l

0.49

106

488

(3033099) Centromere Ab [Titer] in Serum

5.22

13.90

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

410

2.38

13.89

1.7

1.3

—

(3025941) Bacteria identified in Stool by Culture

241

1431

1.74

13.88

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

392

2.41

13.85

1.7

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

394

2.40

13.70

1.7

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.17

13.66

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

5.13

13.62

6.0

3.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

105

3.84

13.59

1.2

1.1

32.50

11.58

u/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

336

2.51

13.49

1.6

1.2

7.89

5.76

u/ml

0.37

152

(3025468) Yersinia sp identified in Specimen by Organism specific culture

392

2.38

13.39

1.7

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1683

14550

1.31

13.26

3.1

2.7

—

(36660697) Celiac disease serology panel - Serum

328

2136

1.59

13.21

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

166

3.17

13.15

1.2

—

(40768806) Pleura Pathology biopsy report

404

2.34

12.97

1.7

1.6

—

(3006969) Lambda light chains [Mass/volume] in Urine

19.10

12.89

1.2

1.1

0.01

0.22

g/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

707

5393

1.39

12.87

4.0

3.1

1.36

1.24

e6/l

0.27

427

2925

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

169

3.11

12.77

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

655

4941

1.40

12.72

4.2

3.2

3.65

2.58

e6/l

1.27

370

2452

(3035637) Corticotropin [Mass/volume] in Plasma

335

2.45

12.61

1.8

1.5

25.74

29.20

ng/l

0.30

335

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

156

3.17

12.46

2.4

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

156

3.17

12.46

2.4

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

156

3.17

12.46

2.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

156

3.17

12.46

2.4

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2871

26942

1.43

12.36

41.0

18.3

28.13

26.12

mg/l

3.25

2771

22694

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.77

12.26

1.4

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

102

475

2.18

12.09

1.8

1.4

2921.17

3642.40

e6/l

0.12

341

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

202

2.85

12.05

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

293

1904

1.59

11.90

6.8

3.4

23.92

24.20

mmol/l

0.82

288

1881

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

290

2.52

11.87

1.4

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

414

2.26

11.85

1.5

1.3

0.20

0.27

nmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.08

11.84

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

346

2.37

11.77

1.5

1.3

—

nmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

135

708

1.94

11.63

2.5

3.3

233.53

929.33

u/ml

0.95

119

647

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

190

2.87

11.58

1.1

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

940

7602

1.33

11.55

3.7

2.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

419

2.23

11.53

1.8

1.4

101900.79

82688.05

e6/l

0.18

239

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.29

11.47

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

295

2.47

11.47

1.8

1.3

9222.47

119980.90

e6/l

1.92

198

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

154

3.08

11.42

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

154

3.08

11.42

1.4

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.67

11.41

1.1

1.4

—

(3004451) EKG impression Narrative

204

2.77

11.28

1.7

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

357

2.30

10.99

1.5

1.3

0.20

0.19

nmol/l

0.24

282

(4035726) Immunohistochemistry procedure

384

2694

1.48

10.94

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.26

10.79

4.9

4.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

270

2.47

10.57

1.1

—

4.32

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

230

2.59

10.44

1.1

—

(3017569) Oxygen content in Arterial blood

191

2.75

10.34

2.3

14.81

16.23

2.47

191

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

267

2.46

10.33

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

102

506

2.05

10.31

1.4

1.3

11.44

11.49

u/l

0.01

413

(3044290) Cell count panel - Cerebral spinal fluid

111

568

1.99

10.30

1.2

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.55

10.23

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

128

690

1.89

10.20

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

128

690

1.89

10.20

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2700

25281

1.34

10.11

6.9

5.6

2.00

1.99

mu/l

0.22

2538

23008

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

145

2.99

9.99

1.0

1.1

1.09

1.15

u/l

0.21

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.91

9.84

1.1

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

368

2616

1.46

9.78

3.0

2.4

0.34

0.54

e6/l

1.79

363

2510

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.59

9.64

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

112

589

1.93

9.63

2.2

1.7

334.45

310.66

mu/l

0.29

101

535

(3026389) Candida sp identified in Specimen by Organism specific culture

394

2.13

9.45

1.6

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

260

1735

1.54

9.40

4.3

2.5

0.65

0.62

0.81

260

1726

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

319

2225

1.48

9.34

2.0

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

256

2.41

9.29

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

9.52

9.25

1.2

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

147

2.88

9.16

1.2

1.5

59.33

66.61

0.66

122

(3009015) Lactate [Moles/volume] in Synovial fluid

5.02

9.09

1.6

1.3

5.76

5.79

mmol/l

—

(40768443) Skin Pathology biopsy report

213

1371

1.59

9.03

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

260

1752

1.52

8.99

4.3

2.5

1.16

1.13

0.24

260

1740

(3022493) Free Hemoglobin [Mass/volume] in Plasma

117

3.10

8.93

1.1

5.6

68.31

66.02

mg/l

0.06

(3024471) HLA-A [Type]

4.20

8.91

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

187

1170

1.63

8.90

2.6

3.3

1109.06

3807.44

u/ml

0.54

156

995

(40768795) Lymph node Pathology biopsy report

280

2.31

8.90

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

243

2.41

8.88

1.2

87.93

104.02

pmol/l

2.27

243

(3000060) B lymphocytes [#/volume] in Blood

4.40

8.61

2.1

1.8

0.25

0.18

e9/l

—

(3018133) Calcium [Moles/volume] in Urine

4.57

8.58

2.0

1.9

2.03

2.87

mmol/l

1.25

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

6.93

8.53

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

114

629

1.84

8.50

1.1

25.06

9.56

eliau/ml

—

(3024932) HLA-DR beta [Type]

4.17

8.45

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

116

3.04

8.42

2.7

1.6

—

(3024928) Oxygen saturation in Venous blood

138

813

1.73

8.26

5.0

2.5

63.00

60.34

0.68

132

784

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

126

728

1.76

8.09

2.0

10.40

12.12

iu/l

0.06

285

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.32

8.06

1.4

1.6

102.66

467.86

nmol/24h

0.59

(3045788) Cell count panel - Pleural fluid

386

2.04

8.02

1.8

1.4

—

(3016135) IgD [Mass/volume] in Serum

22.06

8.01

1.2

1.6

95.25

46.66

mg/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.44

7.89

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

110

3.02

7.88

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

302

2.17

7.88

1.2

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

116

2.95

7.80

2.7

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

116

2.95

7.80

2.7

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.66

7.73

1.0

1.2

1000.00

806.67

titre

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

378

2.03

7.72

1.1

16.66

20.13

au/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

2.65

7.70

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

18.39

7.59

1.3

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

129

2.81

7.58

1.1

1.4

64.75

72.00

—

(3050794) Legionella sp Ab [Presence] in Serum

7.11

7.47

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

195

2.43

7.41

1.1

46.48

40.28

mg/l

0.53

166

(3036670) Protein [Mass/volume] in Synovial fluid

3.05

7.30

1.9

1.3

37.93

39.01

g/l

0.14

(40765096) Chromosome analysis panel by Banding

105

2.97

7.22

1.3

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

326

2394

1.40

7.22

3.3

2.8

48.00

61.76

ml/min/173m2

10.49

187

1072

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.45

7.11

1.3

1.2

1.11

1.75

mmol/l

1.85

(3008295) Osmolality of Serum or Plasma

363

2.00

7.08

1.3

278.07

275.40

mosm/kgh2o

0.45

264

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.61

7.05

15.2

13.6

4.72

5.70

mmol/l

0.91

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

170

2.49

7.00

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

300

2192

1.40

6.85

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

110

645

1.73

6.76

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

3.00

6.65

1.2

15.01

10.99

pmol/l

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

116

2.78

6.63

1.1

23.22

324.20

ng/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

187

2.37

6.62

1.1

211.35

290.21

mg/l

2.77

161

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.22

6.41

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

142

905

1.59

6.36

3.8

3.4

0.79

0.82

nmol/l

0.33

104

730

(3036489) Thrombin time

155

1009

1.56

6.34

2.8

1.9

21.26

21.13

0.11

140

905

(4027681) Cerebrospinal fluid IgG ratio and IgG index

138

2.55

6.19

1.3

1.2

0.56

0.51

ratio

0.44

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

104

2.80

6.15

1.1

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.97

6.10

1.4

1.6

15.90

15.27

pmol/l

0.18

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.76

6.08

5.4

7.6

5.31

5.64

kpa

0.23

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2303

21587

1.21

6.06

43.6

22.5

14.51

13.82

79.56

2286

21253

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

281

2.05

6.02

1.1

1.0

6.27

2.29

eliau/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.69

5.91

1.4

1.2

24.30

765.52

u/l

—

(3028433) Virus identified in Specimen by Culture

2.90

5.88

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

2.48

5.85

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.30

5.85

1.3

1.2

0.58

1.71

mmol/l

0.99

(3001893) Eosinophils/Leukocytes in Pleural fluid

119

2.62

5.80

1.2

1.5

3.27

2.35

0.24

103

(3027923) C peptide [Moles/volume] in Serum or Plasma

155

2.40

5.79

1.1

1.4

1.24

1.12

nmol/l

0.32

110

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

143

2.46

5.77

2.5

3.6

1.13

1.26

0.15

143

(3043409) Potassium [Moles/volume] in Arterial blood

139

904

1.56

5.74

4.2

3.9

3.97

3.89

mmol/l

1.06

139

897

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

157

2.37

5.63

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

368

2865

1.32

5.61

3.3

2.3

30.87

39.66

u/l

2.75

320

2386

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

189

2.24

5.60

1.3

0.86

1.84

u/ml

0.47

105

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.41

5.58

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

216

2.15

5.53

4.2

2.8

35.30

30.22

mg/l

0.37

162

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

111

2.63

5.47

1.1

1.3

652.27

383.59

ug/l

0.15

(3034426) Prothrombin time (PT)

3.24

5.44

1.5

1.3

33.80

28.34

0.87

(3020191) Ethanol [Moles/volume] in Serum or Plasma

185

2.23

5.44

1.6

1.4

1.12

1.08

promille

0.08

143

(3044889) 12 lead EKG panel

2101

19625

1.19

5.35

5.8

4.5

0.40

2020.76

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.87

5.35

1.1

1.0

—

(3024263) Appearance of Synovial fluid

156

2.32

5.25

2.2

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.76

5.20

1.2

1.4

10.59

13.44

g/l

0.79

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

2.80

5.14

1.4

43.29

29.55

0.82

(3049717) Cytology report of Urine Cyto stain

180

1267

1.44

5.11

2.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.18

5.03

3.2

2.8

3.11

516.02

ug/l

0.55

(3040151) Glucose [Moles/volume] in Capillary blood

395

1.79

5.01

3.7

5.5

7.69

7.41

mmol/l

0.30

327

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.04

4.94

2.2

1.5

0.18

0.28

mmol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

142

2.34

4.91

2.2

1.8

3.17

2.65

u/field

0.21

(3013727) Leukocytes other/Leukocytes in Blood

2.67

4.91

2.7

4.4

57.88

55.88

0.16

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

124

2.43

4.87

1.9

1.8

71.66

52.43

ug/l

0.51

119

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

269

1.95

4.87

2.4

2.1

1.12

1.54

u/field

0.47

132

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

125

2.41

4.80

2.7

2.3

75.33

134.99

umol/l

1.05

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1375

0.62

4.77

1.8

3.40

3.46

mmol/l

0.14

996

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.17

4.76

1.2

1.6

5.25

7.36

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

208

1524

1.39

4.74

2.9

3.9

61.44

88.09

u/ml

0.81

202

1470

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

126

2.39

4.72

1.0

1.1

22.54

17.40

u/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

102

2.56

4.71

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

140

2.30

4.61

1.2

1.6

—

(40758292) HTLV I+II Ab panel - Serum

3.34

4.60

1.9

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.13

4.60

1.4

1.1

—

(3019150) Specific gravity of Urine by Refractometry

782

6782

1.20

4.59

6.5

4.5

1.02

1.24

kg/l

0.50

599

4558

(3044242) Glucose [Moles/volume] in Arterial blood

201

2.05

4.48

2.1

2.0

8.25

8.18

mmol/l

0.03

201

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.80

4.44

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.80

4.44

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.80

4.44

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

143

992

1.46

4.43

1.5

1.6

36.67

20.39

u/ml

0.84

181

(3024869) Neuronal Ab [Presence] in Serum

3.21

4.33

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

1306

0.63

4.33

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

130

1864

0.69

4.32

2.0

3.48

3.39

ratio

0.28

101

1483

(3011397) Hemoglobin [Presence] in Urine by Test strip

826

7236

1.19

4.30

6.0

4.1

0.13

0.12

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

11.69

4.27

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

859

7562

1.18

4.21

1.5

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

4.13

4.20

4.8

7.2

9.81

10.46

0.51

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2658

25536

1.19

4.15

8.9

6.9

41.98

39.92

mmol/mol

20.62

2490

23498

(3052851) Hemolysis interference index of Serum or Plasma

127

873

1.47

4.14

4.7

3.6

1.06

1.85

index

1.82

438

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

109

2.40

4.14

1.1

2.5

188.15

167.95

0.45

103

(3019550) Sodium [Moles/volume] in Serum or Plasma

2879

27870

1.22

4.12

41.5

22.2

138.93

139.60

mmol/l

32.37

2846

27255

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

188

2.03

4.08

2.0

1.6

461.32

329.78

mu/l

0.62

148

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.09

4.08

1.4

1.1

—

(40768804) Tissue Pathology biopsy report

1270

11555

1.16

4.07

2.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.64

4.06

1.1

1.2

40.14

9.93

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

112

756

1.50

4.01

1.3

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

204

1.97

3.96

3.0

1.8

101.78

115.35

ng/l

0.34

204

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

315

1.76

3.83

3.9

2.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2879

27911

1.21

3.83

42.1

22.4

4.02

3.99

mmol/l

6.67

2843

27246

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.30

3.81

1.3

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

435

3625

1.23

3.81

1.5

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2029

21407

0.87

3.79

45.6

23.9

327.03

331.05

g/l

66.88

2016

21243

(3023410) Appearance of Cerebral spinal fluid

272

1.81

3.78

1.3

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

114

784

1.47

3.74

1.4

29.11

29.75

iu/l

0.07

666

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

128

2.20

3.70

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.43

3.63

3.7

1.9

—

(3014891) Appearance of Pleural fluid

2.87

3.62

1.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

530

1.56

3.61

3.0

1.5

1.05

0.79

nmol/l

2.15

436

(3002079) Sodium [Moles/time] in 24 hour Urine

117

2.23

3.57

1.1

1.2

158.88

160.15

mmol/24h

0.02

117

(3052592) Norovirus Ag [Presence] in Stool

2.66

3.56

1.2

1.4

—

(40757373) Influenza virus identified in Isolate

2.58

3.54

1.3

1.4

—

(4212803) Bone marrow aspirate examination

4.24

3.50

1.4

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.17

3.50

2.1

4.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.88

3.48

1.9

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.42

3.46

1.2

1.3

108.40

118.66

nmol/l

0.13

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

154

2.02

3.35

1.2

1.1

9.67

7.62

iu/ml

—

(40757494) Bilirubin.total [Moles/volume] in Blood

162

1.98

3.29

2.5

2.1

—

17.71

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

111

782

1.43

3.26

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.75

3.23

2.1

2.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.51

3.20

1.4

1.1

—

(44806420) Estimation of glomerular filtration rate

266

1.74

3.15

2.7

2.4

—

(4015189) Microbial culture of sputum

2.41

3.13

2.3

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.41

3.13

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

328

1.66

3.11

1.1

—

(3016038) Potassium [Moles/volume] in Urine

238

1.77

3.09

1.3

1.1

26.19

34.83

mmol/l

2.19

208

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

298

1.69

3.09

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

2.20

3.09

3.2

2.4

0.61

0.62

mmol/l

0.38

105

(3019174) dRVVT (LA screen)

4.01

3.08

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

4.01

3.08

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

109

775

1.42

3.06

1.2

—

(4195642) Thrombophilia screening test

307

1.67

3.04

1.1

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.59

3.04

1.6

1.0

231.78

263.39

pmol/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

110

788

1.41

2.97

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

564

1.48

2.96

1.3

135.07

226.55

miu/ml

1.15

243

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

443

1.55

2.95

2.6

2.2

25.71

21.76

mg/l

0.32

154

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

321

3841

0.82

2.94

1.5

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

4.71

2.92

1.5

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.70

2.88

1.0

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

289

1.67

2.88

1.2

1.3

1.50

1.52

nmol/l

0.03

261

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.71

2.87

1.3

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

253

1.71

2.81

1.5

1.3

24.86

30.95

u/l

0.65

209

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.65

2.79

1.0

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

8.34

2.75

1.0

1.2

0.27

0.23

g/l

—

(3033086) Enterovirus Ab [Titer] in Serum

8.34

2.75

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

8.34

2.75

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

145

1.94

2.74

1.5

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

676

1.42

2.70

5.3

2.2

63.52

60.78

0.56

671

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.01

2.70

1.2

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.46

2.69

2.0

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.22

2.67

1.0

6.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.29

2.67

1.2

2.7

175.50

179.60

0.08

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

119

2.02

2.66

6.2

5.0

46.40

59.65

u/ml

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

393

1.54

2.59

1.1

13.80

49.26

iu/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.06

2.56

1.7

1.4

—

(3042517) Benzodiazepines panel - Urine

5.46

2.54

2.0

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

2.23

2.53

1.7

1.6

960.00

3040.00

titre

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

115

2.01

2.50

1.1

1309.39

1640.87

miu/ml

0.83

115

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2872

28043

1.16

2.48

22.8

12.7

23.94

24.46

u/l

0.78

2829

27004

(3020393) Adenovirus Ag [Presence] in Stool

3.47

2.48

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

311

1.58

2.44

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.24

2.44

1.0

1.1

90.00

84.18

—

(3020650) Glucose [Presence] in Urine

2.09

2.42

1.6

2.0

0.00

0.06

estimate

0.80

(4211845) Urine protein measurement

149

1.82

2.24

5.2

4.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.11

2.22

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.34

2.21

1.3

1.1

—

(3006270) Folate [Moles/volume] in Blood

272

1.59

2.20

1.0

1.2

290.53

340.97

nmol/l

0.88

231

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

539

0.61

2.17

1.3

1.2

1.52

1.57

g/l

0.50

539

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.29

2.15

5.2

3.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

387

1.48

2.13

3.7

5.0

340.92

345.96

umol/l

0.12

338

(3008401) Mugwort IgE Ab [Units/volume] in Serum

300

1.54

2.08

1.0

0.37

1.20

u/ml

1.14

124

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

5.01

2.07

1.0

318.60

251.60

nmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.33

2.04

2.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.18

2.04

1.5

1.6

10.86

9.43

ug/l

0.57

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.11

2.02

1.0

1.4

87.36

83.26

0.13

(3010726) Horse dander IgE Ab [Units/volume] in Serum

271

1.56

2.00

1.0

1.29

1.03

u/ml

0.16

140

(3003888) Timothy IgE Ab [Units/volume] in Serum

305

1.52

1.95

1.0

3.88

4.08

u/ml

0.03

146

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.36

1.95

1.2

1.1

19.62

9.19

u/ml

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

4.55

1.94

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

242

0.45

1.93

1.2

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.73

1.93

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.12

1.92

1.3

1.17

mmol/l

0.09

(3013139) Helicobacter pylori Ag [Presence] in Stool

232

1956

1.20

1.90

1.2

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

143

1.75

1.88

1.2

1.1

151.92

134.64

nmol/l

1.04

143

(3032057) Clostridioides difficile [Presence] in Stool

2.09

1.86

1.7

1.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.53

1.83

2.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

318

1.48

1.83

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.05

1.80

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

369

1.44

1.79

1.0

1.1

5.44

1.49

u/ml

0.94

201

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.96

1.79

1.8

1.3

32.33

24.23

0.37

(3006462) Nitrate [Presence] in Urine

138

1.74

1.79

5.7

4.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1183

11146

1.09

1.74

2.2

1.9

1.40

1.31

mmol/l

3.32

938

9187

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

117

1.80

1.74

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

355

1.44

1.74

1.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.74

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

495

0.64

1.73

1.1

0.57

0.64

ratio

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.85

1.71

5.8

2.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2631

25698

1.11

1.71

33.7

18.2

70.77

75.01

ml/min/173m2

16.36

2531

23990

(4146454) Self-monitoring of blood glucose

366

1.43

1.68

2.8

2.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.58

1.66

1.4

1.3

—

640.53

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.80

1.65

1.1

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

220

1.55

1.65

1.9

1.8

6.82

10.32

umol/l

0.59

150

(3002523) Influenza virus A Ag [Presence] in Specimen

318

1.45

1.64

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

395

1.40

1.60

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.50

1.59

1.9

1.6

—

(3014271) Vancomycin [Susceptibility]

199

1.56

3.5

3.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.28

1.55

1.2

86.40

84.18

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

576

0.69

1.55

1.5

1.2

0.92

0.89

g/l

0.31

576

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2667

26108

1.10

1.53

6.4

5.5

6.20

6.01

mmol/l

8.32

2452

23488

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2895

28466

1.12

1.51

46.4

24.4

92.24

80.31

umol/l

24.88

2868

28035

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

168

0.47

1.46

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

219

1.51

1.46

1.4

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.50

1.45

1.0

123.43

94.86

titre

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.04

1.43

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

102

819

1.25

1.41

4.8

4.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.42

1.39

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.20

1.37

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.61

1.36

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

464

5084

0.90

1.36

3.5

3.3

0.74

0.75

ug/l

0.19

334

3549

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.94

1.36

1.0

—

1.96

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.83

1.35

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2521

24672

1.09

1.31

4.9

4.4

1.37

1.26

mmol/l

9.54

2297

22130

(3022689) Creatine [Moles/volume] in Urine

1.81

1.31

1.2

1.5

6.15

7.16

mmol/l

0.53

(3000034) Microalbumin [Mass/volume] in Urine

242

1.45

1.30

3.6

3.0

180.02

23.33

mg/l

0.69

183

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.85

1.29

1.9

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

190

1638

1.17

1.29

2.5

2.2

10.97

12.77

nmol/l

1.98

163

1441

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.78

1.28

5.8

2.1

27.60

25.51

mg/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.79

1.27

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.29

1.26

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

345

1.37

1.26

2.3

1.9

—

(40768800) Prostate Pathology biopsy report

388

1.35

1.26

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

173

1485

1.17

1.24

1.7

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

237

1.44

1.22

1.0

9.14

3.13

u/ml

0.90

112

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.83

1.19

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

222

1.45

1.18

1.0

1.1

10.07

4.27

u/ml

0.58

(3020491) Glucose [Moles/volume] in Blood

215

1.45

1.15

2.1

2.6

8.66

6.83

mmol/l

1.43

146

(3032868) Hemoglobin electrophoresis panel in Blood

2.50

1.15

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

126

1.59

1.14

1.3

—

(3002256) Pathology report gross observation

435

3990

1.10

1.14

1.3

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.38

1.09

1.4

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.95

1.08

1.6

1.5

47.63

44.93

umol/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.76

1.06

1.9

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

129

1.55

1.05

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

375

1.31

1.04

1.9

1.5

—

(4198724) Urine methamphetamine measurement

1.88

1.00

1.4

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

189

1.43

0.99

2.5

2.4

—

(3005570) Glucose [Moles/volume] in Urine

309

1.33

0.98

2.9

2.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.18

0.98

1.4

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.95

0.97

1.4

2.0

11.84

17.82

umol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

0.95

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.14

0.91

1.2

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

261

1.34

0.91

1.4

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.07

0.89

1.7

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.07

0.89

1.7

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

0.06

0.02

u/ml

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.07

0.89

1.7

1.1

—

(1002224) Polysomnography panel

903

0.83

0.88

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

182

1617

1.13

0.88

1.9

2.0

—

(3000330) Specific gravity of Urine by Test strip

188

1678

1.13

0.85

4.2

3.6

1.02

ratio

0.32

171

1529

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

170

1.41

0.85

2.0

1.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

547

0.78

0.84

3.3

4.0

31.63

35.97

u/ml

0.14

531

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

129

1.48

0.83

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

525

1.22

0.82

2.5

2.0

4632.79

5251.85

u/l

0.05

221

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

194

1740

1.12

0.82

1.3

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

920

8811

1.06

0.82

5.6

5.4

4.27

3.53

ug/l

0.21

809

7807

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2637

26006

1.06

0.79

5.9

5.3

4.38

4.52

mmol/l

10.35

2449

23800

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.82

0.79

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.59

0.78

1.6

1.2

33.54

10.91

mm/h

2.37

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.59

0.78

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.70

0.75

5.1

6.3

7.89

8.27

mmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.60

0.74

1.5

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

351

1.26

0.74

2.0

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

391

0.77

0.73

1.5

—

(4034850) Laboratory test

894

0.85

0.73

21.4

11.4

—

(3025577) Chromium [Mass/volume] in Blood

193

1.35

0.73

2.1

2.3

1.43

2.10

ug/l

1.59

165

(3000285) Sodium [Moles/volume] in Blood

1.58

0.71

1.2

1.3

138.42

138.66

mmol/l

0.08

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.92

0.70

5.6

2.5

0.00

0.88

u/field

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.92

0.70

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

585

0.82

0.68

1.7

1.6

751.83

982.95

mu/l

1.62

490

(3004716) Salmonella sp identified in Stool by Organism specific culture

130

1155

1.13

0.68

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2613

25801

1.06

0.67

5.7

5.2

1.40

1.47

mmol/l

16.43

2407

23435

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

270

1.26

0.62

1.3

1.4

0.28

0.31

nmol/l

0.25

206

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.46

0.61

1.1

—

(3022621) pH of Urine by Test strip

261

2428

1.08

0.58

3.4

3.0

5.91

6.06

2.16

175

1725

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

403

3810

1.07

0.57

5.2

32.81

33.35

0.40

296

2423

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.62

0.55

3.2

2.5

1.32

0.64

ug/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.62

0.55

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

329

0.79

0.55

1.8

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.58

0.54

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

160

1.31

0.53

1.0

—

(3002619) Bacteria identified in Specimen by Culture

1.41

0.51

1.7

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2904

28816

1.05

0.51

55.3

27.7

7.50

6.86

e9/l

42.24

2865

27994

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

324

0.80

0.49

1.6

1.5

1.11

0.96

ratio

1.03

209

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

324

0.80

0.49

1.6

1.5

0.96

1.15

ratio

0.85

209

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

324

0.80

0.49

1.6

1.5

1.04

1.23

ratio

0.67

209

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

243

1.24

0.49

4.0

5.5

27.97

41.58

u/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

207

1.26

0.49

1.0

0.21

0.20

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

1.56

0.49

1.1

1.3

61.71

67.29

ug/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2681

26565

1.04

0.47

6.5

6.1

2.49

2.60

mmol/l

8.05

2482

24216

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

321

0.81

0.46

1.6

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

277

0.79

0.46

1.6

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

191

1.26

0.46

1.7

1.6

97.25

86.10

umol/l

0.81

191

(4094501) Cardiovascular stress test using bicycle ergometer

727

0.88

0.45

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

2901

28806

1.05

0.44

55.3

27.7

265.31

246.57

e9/l

31.22

2871

28107

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

174

1.27

0.44

1.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2901

28810

1.05

0.43

55.1

27.6

92.11

91.60

5.61

2874

28374

(3035941) MCH [Entitic mass]

2901

28811

1.05

0.43

55.0

27.6

30.16

30.37

6.72

2873

28375

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2901

28812

1.05

0.43

56.1

28.2

37.24

39.51

92.05

2874

28362

(3026361) Erythrocytes [#/volume] in Blood

2901

28812

1.05

0.43

55.2

27.7

4.11

4.39

e12/l

128.31

2857

27993

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.61

0.43

1.0

1.2

1.64

1.76

umol/24h

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.61

0.43

1.0

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

322

1.18

0.42

4.2

3.5

13.79

11.46

index

0.96

168

(3000963) Hemoglobin [Mass/volume] in Blood

2901

28818

1.05

0.41

55.7

27.9

122.64

132.23

g/l

193.36

2872

28394

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

228

0.79

0.41

1.8

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

348

0.83

0.41

1.6

1.5

51.65

61.89

ug/l

1.21

293

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.40

0.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.40

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.41

0.39

1.4

1.7

—

(3016879) Cocaine [Presence] in Urine

447

1.14

0.39

1.9

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.39

0.38

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

477

1.13

0.37

1.9

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

268

0.82

0.37

1.6

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.37

0.34

1.6

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.36

0.34

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.36

0.34

1.2

1.0

18.27

39.66

iu/ml

—

(3005033) Fetal Nuchal fold Thickness US

265

0.83

0.34

1.6

1.5

1.34

1.28

0.24

195

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.30

0.33

4.0

2.2

10.75

10.09

kpa

0.37

100

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.30

0.33

4.0

2.2

5.23

4.79

kpa

0.73

100

(3027944) Amphetamines [Presence] in Urine

472

1.12

0.33

1.9

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

231

0.82

0.32

1.0

928.92

696.46

ng/l

0.96

145

(3001019) Free T4 and TSH panel - Serum or Plasma

905

0.92

0.32

1.4

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

119

1.26

0.31

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

273

0.84

0.31

1.6

1.7

—

(40768793) Breast Pathology biopsy report

771

0.92

0.27

1.3

—

(1761868) Lipid panel - Serum or Plasma

889

8722

1.03

0.27

3.9

3.4

—

(3028300) Cannabinoids [Presence] in Urine

482

1.10

0.25

1.9

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

242

0.87

0.22

1.9

1.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

46.70

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.13

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.12

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.16

0.21

1.2

1.1

34.12

40.94

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.77

—

(3027008) Opiates [Presence] in Urine

479

1.09

0.21

1.9

1.5

—

(4133840) Spirometry

1.15

0.19

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

121

0.83

0.18

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

383

3747

1.02

0.16

14.2

7.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.79

0.15

1.3

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

596

0.94

0.15

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

124

1280

0.97

0.12

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

782

0.96

0.11

1.6

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

758

0.96

0.10

1.9

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.78

0.08

2.0

1.6

—

0.59

—

(3044007) Cell count panel - Peritoneal fluid

1.12

0.07

1.7

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.83

0.07

1.0

1.5

—

(4281824) Cell count and differential, peritoneal fluid

333

1.05

0.07

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

704

6990

1.01

0.07

4.8

4.5

21.69

22.99

1.55

358

3595

(4024509) Urine culture

157

1542

1.02

0.07

2.2

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

649

0.97

0.06

5.1

3.7

32.36

27.57

mg/l

0.62

459

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

920

1.02

0.05

2.0

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

199

0.95

0.03

1.7

1.6

51.45

54.41

ug/l

0.13

199

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

173

1.04

0.01

1.1

1.6

3.02

4.19

ug/l

0.30

140

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

106

0.94

0.01

2.3

2.9

29.80

29.57

umol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

109

1.01

0.00

1.1

1.4

137.63

157.66

pmol/l

0.17

109

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

286

1.01

0.00

1.3

7.73

7.57

mmol/l

0.11

242

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

154

0.97

0.00

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

164

0.98

0.00

5.3

7.0

22.72

120.04

ug/l

—

102

(3025130) Human papilloma virus identified in Specimen

323

0.99

0.00

1.9

1.8

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

1.76

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.1

—

1.55

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.65

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

2.11

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.37

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO – Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity (R18_ELEVATED_ERYTHROCYTE_SEDIM_RATE_ABNORMALITY_PLASMA_VISCO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints